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ABSTRACT 
CELLULAR AND MOLECULAR CHANGES FOLLOWING SKELETAL MUSCLE 
DAMAGE: A ROLE FOR NF-kB AND MUSCLE RESIDENT PERICYTES 
SEPTEMBER 2011 
ROBERT D. HYLDAHL, B.S., UNIVERSITY  OF UTAH 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Priscilla M. Clarkson 
  
Skeletal muscle is dynamic and actively regenerates following damage or altered 
functional demand. Regeneration is essential for the maintenance of muscle mass and, 
when dysregulated as a result of disease or aging, can lead to losses in functional capacity 
and increased mortality. Limited data exist on the molecular mechanisms that govern 
skeletal muscle regeneration in humans. Therefore, the overall objective of this 
dissertation was to characterize early molecular alterations in human skeletal muscle to 
strenuous exercise known to induce a muscle regenerative response.  Thirty-five subjects 
completed 100 eccentric  (muscle lengthening) contractions (EC) of the knee extensors 
with one leg and muscle biopsies were taken from both legs 3 h post-EC. The sample 
from the non-EC leg served as the control. A well-powered transcriptomic screen and 
network analysis using Ingenuity Pathway software was first conducted on mRNA from 
the biopsy samples. Network analysis identified the transcription factor NF-kappaB (NF-
kB) as a key molecular element affected by EC. Conformational qRT-PCR confirmed 
alterations in genes associated with NF-kappaB. A transcription factor ELISA, using 
nuclear extracts from EC and control muscle samples showed a 1.6 fold increase in NF-
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kB DNA binding activity following EC. Immunohistochemical experiments then 
localized the majority of NF-kB positive nuclei to cells in the interstitium, which stained 
positive for markers of pericyte cells and not satellite cells. To ascertain the mechanistic 
significance of NF-kB activation following muscle damage, in vitro analyses were carried 
out using a novel primary pericyte/myoblast co-culture model. Primary pericyte/myoblast 
co-culture experiments demonstrated that pericytes, transfected with a DNA vector 
designed to drive NF-kB activation, enhanced proliferation and inhibited myogenic 
differentiation of co-cultured skeletal muscle myoblasts. Furthermore, reduced NF-kB 
activation led to enhanced myogenic potential of primary pericytes. Taken together, the 
data in this dissertation suggest that NF-kB dependent signaling in pericytes regulates 
myogenic differentiation in a cell- and non-cell autonomous manner and may affect the 
early regenerative response following muscle damage by inhibiting differentition and 
promoting proliferation of muscle satellite cells. 
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CHAPTER I 
AIMS AND HYPOTHESES 
 
Introduction 
 
Skeletal muscle represents the largest portion of tissue in the human body and is unique 
among tissues in its remarkable ability to repair and regenerate itself in response to 
changing functional demands and/or damage. Given its essential roles in locomotion, heat 
production and energy storage, the regenerative capacity of skeletal muscle is paramount 
to normal, healthy function. In fact, when a muscle’s regenerative capacity is 
compromised or exhausted, as in the case of aging or muscle degenerative diseases, 
dysfunction and premature death often result (15). The complex mechanisms that regulate 
a muscle’s ability to regenerate rely on the intricate interactions and signaling patterns 
between the regenerating myofibers, muscle progenitor cells (MPCs), immune cells and 
other systemic factors.  
 
Statement of the Problem 
There is strong supporting evidence for the activation of muscle regenerative events, as 
early as 2 hours following a damaging stimulus (4). However, the initial signaling 
molecules and pathways, as well as the origin of the signals associated with these events 
following damage are poorly understood, particularly in human muscle. In fact, the 
majority of studies on muscle regeneration performed to date (and 95% of the studies 
cited in this review) have been conducted in vitro or in animal models. Due primarily to 
their facilitation of genetic manipulations, these models have provided and will continue 
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to provide the basis for mechanistic research in muscle regeneration. Nevertheless, given 
recent emphases for translational research and the possible implications of muscle 
regenerative work for an aging population, as well as for those afflicted with muscular 
diseases, future studies will need to specifically address observations made in human 
muscle. Therefore, the overall objective of this dissertation will be to further 
characterize and identify early novel changes in molecular pathways and signaling 
following muscle damage in humans.  
 
Experimental Approach 
To address the overall dissertation objective, I have taken a translational approach by 
conducting an unbiased genome wide screen and follow-up analyses in human muscle 
samples following eccentric exercise-induced muscle damage. These observations were 
then used to develop mechanistic hypotheses that I tested using an in vitro paradigm of 
myogenesis. Subsequent chapters will present the results of these studies.  In Chapter 3 I 
present a detailed descriptive study, highlighting novel molecular and cellular changes in 
human muscle following eccentric contractions.  Chapter 4 presents the mechanistic 
resolution of the observations from the human study in the context of muscle 
regeneration. Additionally, a third published study has been included in the appendix to 
further underscore the value of using in vitro models to elucidate the mechanistic 
relationships of observations made in human muscle. 
 
Significance 
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The results of this dissertation will enhance our understanding of muscle regenerative 
molecular pathways and may provide the basis for development of early interventions 
following muscle injury. Furthermore, they will also provide valuable mechanistic 
information on potential molecular targets to drive repair in muscle degenerative diseases 
such as Duchenne muscular dystrophy.  
 
Specific Aims Study 1: Global Gene Expression Changes Following Eccentric 
Exercise-Induced Damage 
The first step in addressing my dissertation objective of identifying early novel changes 
in molecular pathways and signaling following muscle damage was to take an 
exploratory approach by assessing global gene expression changes. I used microarray 
technology and Ingenuity Pathway software analysis to take a systems approach. 
Although others, including our own lab group, have used microarray to assess global 
gene expression following eccentric exercise (3, 9, 10), small sample size in these studies 
has always precluded a meaningful systems approach. Also, As noted by the Tumor 
Analysis Best Practices Working Group (1), the interpretation of microarray generated 
data can be significantly compromised when the number of replicates are low. Therefore, 
the primary aims for this dissertation were to: 
 
Specific Aim #1: Use whole genome analysis and a systems analysis to identify genes 
and pathways that are modified 3 hours following an intense eccentric exercise in a large 
human subject population.  
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Hypothesis #1: Whole genome analysis will confirm reports of previously identified 
differentially expressed genes following eccentric exercise and provide a novel profile of 
genes and networks that are differentially expressed.  
Experimental Design: Muscle biopsies were taken from the vastus lateralis muscle of 35 
male subjects 3 h post-100 maximal eccentric contractions (EC). Biopsies were taken 
from the EC leg and the non-exercised control leg. Muscle damage was then confirmed 
via measures of strength loss, soreness and serum creatine kinase (CK) pre-EC and for 5 
days post-EC. Total RNA was extracted from the control and EC biopsy sample, 
converted to cDNA, labeled and hybridized to an Agilent Whole Genome Microarray. 
Raw values from the microarray were log transformed and normalized. Values from the 
control and EC samples were compared using an ANCOVA and significantly altered 
genes were input into Ingenuity Pathway Analysis software for systems analysis. qRT-
PCR was then used to confirm alterations in genes that were indicated by the microarray 
analysis.  
Brief Results: Indirect markers of muscle damage indicated a moderate level of muscle 
damage, characterized by the development of soreness, increases in serum CK, and 
decreases in strength. Ingenuity Pathway Analysis revealed multiple significant gene 
networks with relevant functions relating to inflammatory and immunologic response, 
cell growth and proliferation and cell signaling. The transcription factor nuclear factor-
kappa-B (NF-kB) was highlighted in several of these networks. Subsequent 
conformational analysis, using qRT-PCR confirmed alterations in several transcripts 
associated with NF-kB activation. Collectively, the results of Study 1 suggested that NF-
kB activation may be an important molecular response following EC. 
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Specific Aims Study 2: Activation of NF-kB Following Eccentric Exercise-Induced 
Damage 
NF-kB is a heterodimeric protein complex that is found in the cytosol in its inactive form. 
Upon activation, via several well-described mechanisms (2), it is released from its protein 
inhibitor (Ikb) and can translocate to the nucleus, where it activates transcription of a host 
of genes. In addition to its most well characterized function as a pro-inflammatory 
transcription factor, NF-kB is also involved in developmental processes, cell growth, cell 
proliferation and apoptosis. NF-kB is sensitive to reduction/oxidation reactions and has 
been shown to be activated by reactive oxygen species (ROS) in several different cell 
types (7).  
 
Given that EC-induced muscle damage results in a predictable and well-characterized 
inflammatory and oxidative stress response (11, 14), it would be logical to surmise that 
NF-kB is activated following EC. In rodents, treadmill running, which has a strong 
eccentric component, has been shown to increase NF-kB binding activity, enhance Ikk 
phosphorylation and increase IL-6 mRNA expression, all of which suggest activation of 
NF-kB (8, 13). Surprisingly, in humans, this observation has never been made. In Study 
#1, the network analysis indicated possible NF-kB activation following EC in humans. 
Therefore, the Aims of Study #2 were to:  
 
 6	  
Specific Aim #1: Determine if NF-kB is activated in human skeletal muscle following 
eccentric exercise compared with the non-exercised control leg. 
Hypothesis #1: Transcription factor DNA binding analysis and confocal microscopy will 
show that NF-kB is activated in skeletal muscle following eccentric exercise compared to 
non-exercised muscle. 
Experimental Design: An ELISA-based transcription factor DNA binding assay was 
used to assess the activation of NF-kB in nuclear extracts from the control and EC biopsy 
samples. Further support for NF-kB activation was gathered using immunohistochemistry 
and confocal microscopy. An antibody against the p65 subunit of NF-kB was used in 
conjunction with a nuclear stain on serial cross sections of control and EC muscle 
samples. Confocal images were then acquired and the co-localization of the NF-kB and 
nuclear signals indicated the presence of NF-kB in the nuclei, providing an indirect 
measure of NF-kB activity. 
Brief Results: By transcription factor ELISA, a significant 1.6 fold increase in NF-kB 
DNA binding activity was found in samples from the EC vs. the control leg. 
Quantification of the confocal images showed a greater percentage of nuclei that were 
positive for NF-kB in the EC compared to the control leg. Together, these data provide 
strong support for the activation of NF-kB 3 h following EC. 
 
Specific Aim #2: Determine both the cell type and subcellular localization of NF-kB 
activation in human skeletal muscle following eccentric exercise. 
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Hypothesis #2: Immunohistochemistry (IHC), using antibodies against the p65 subunit of 
NF-kB and dystrophin will indicate the location (myonuclei vs. non-myonuclei) of 
expression and co-localization with nuclei in cross-sections of EC and control muscles. 
Experimental Design: Immunofluorescent images of serial sections stained for the p65 
subunit of NF-kB, dystrophin and nuclei were analyzed for co-localization of NF-kB to 
individual nuclei. The presence of the dystrophin stain provided information on whether 
the NF-kB positive nuclei were located inside the myofiber (myonuclei) or outside the 
myofiber (non-myonuclei). Follow-up analyses using antibodies against the p65 subunit 
of NF-kB and markers for various muscle resident cell types helped to identify the 
predominant cellular compartment of NF-kB activity. 
Brief Results: Enumeration of NF-kB positive nuclei demonstrated that a significantly 
greater percentage of non-myonuclei with activated NF-kB than myonuclei. In fact, 
localization of NF-kB to myonuclei was a rare occurrence. Also noted was that a high 
number of these NF-kB positive non-myonuclei were positioned adjacent to or nearby 
what was perceived to be potential sites of microvasculature, as indicated by a tubular 
p65 staining pattern. This observation led to the hypothesis that NF-kB was being 
activated in cells associated with the microvasculature. Thus, muscle sections were co-
stained with markers of vessel-associated pericyte cells and satellite cells. It was found 
that NF-kB localized predominately to cells that stained positive for markers of pericytes, 
indicating that pericytes, not satellite cells are the primary source of NF-kB activity in 
muscle following EC.  
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Specific Aims Study 3: The Effect of Pericyte Specific NF-kB Activation on 
Myogenic Response 
The objectives of Study #1 and Study #2 were to use a paradigm of muscle damage in 
humans to further characterize early novel molecular changes that may be associated with 
muscle regeneration and adaptation. Preliminary observations from those studies 
suggested that activation of NF-kB in muscle residing pericytes may be an important 
event, although its significance within the framework of muscle regeneration (the overall 
dissertation objective) is yet unknown.  
 
Recent attention has been paid to the role that NF-kB signaling plays in the myogenic 
response of developing and regenerating muscle (2, 5). In fact, there is ongoing debate as 
to whether it has primarily pro- or anti-myogenic effects, although there is strong 
emerging evidence to support the idea that the cellular compartmentalization of its 
activity is a key factor in its function (5). Similarly, there has been recent interest in the 
myogenic potential of muscle resident pericyte cells in normal and dystrophic skeletal 
muscle (6). Whether pericytes are myogenic and contribute to the muscle regenerative 
response following damage is unknown. Likewise, it is unknown if NF-kB signaling is 
important in the myogenic differentiation of pericytes following muscle damage or how 
NF-kB signaling in these cells may affect overall muscle regeneration by possible 
signaling relationships with other muscle progenitor cells (myoblasts/satellite cells). 
Thus, study #3 followed up on the functional relevance of pericyte specific NF-kB 
activation following muscle damage by employing an in vitro co-culture 
(pericyte/myoblast) model of myogenesis to understand how NF-kB dependent signaling 
 9	  
between these two cell types affects myogenic differentiation of myoblasts. In this model, 
I have both driven and inhibited NF-kB activity in pericyte cells and measured changes in 
myogenic and proliferative activity of C2C12 myoblasts. The specific aims of Study #3 
were to: 
 
Specific Aim #1: Determine the effect of altered NF-kB activation on the myogenic fate 
of primary pericyte cells in co-culture with C2C12 myoblasts and alone (monoculture) 
under differentiation conditions. 
Hypothesis #1a: Enhanced NF-kB activation will result in decreased myotube formation 
in primary pericyte monocultures under differentiation conditions and a decreased 
contribution to myotube formation in co-culture with C2C12 myoblasts.  
Hypothesis #1b: Diminished NF-kB activation will result in increased myotube 
formation in primary pericyte monocultures under differentiation conditions and an 
increased contribution to myotube formation in co-culture with C2C12 myoblasts. 
Experimental Design: To test the effect of pericyte specific NF-kB activation on indices 
of myogenesis, I have transfected human placental-derived primary pericytes with 
expression vectors designed to enhance or diminish NF-kB activation. Transfected 
pericytes were then cultured under differentiation conditions in monoculture or in co-
culture with differentiated C2C12 myotubes. IHC and Western blot were used to determine 
the level of pericyte differentiation in monoculture. For co-culture experiments, 
transfected pericyte nuclei were labeled with BRDU and pericytes were co-cultued with 
4-day differentiated myotubes. Following 3 days in co-culture, IHC, using an antibody 
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against BRDU was used to identify and quantify the pericyte nuclei within C2C12 
myotubes. 
Brief Results: Despite published reports of spontaneous myogenic differentiation of 
placental-derived primary pericytes under reduced growth factor conditions (12), I was 
unable to observe evidence of myogenic differentiation, regardless of NF-kB activation 
status in monoculture. However, when pericytes were co-cultured with differentiated 
C2C12 myotubes, there was evidence of myogenic fusion to myotubes. Furthermore, as 
expected, diminished NF-kB activity significantly increased the relative number of 
myogenic pericytes compared to the control condition.  
 
Specific Aim #2: Determine the effect of pericyte specific NF-kB activation on myoblast 
proliferation and myogenesis in an in vitro co-culture model. 
Hypothesis 2a: Co-culture of myoblasts and primary pericytes, transfected with an 
expression vector to enhance NF-kB activation will result in increased myoblast 
proliferation and increased myotube formation. 
Hypothesis 2a: Co-culture of myoblasts and primary pericytes, transfected with an 
expression vector to diminish NF-kB activation will result in decreased myoblast 
proliferation and decreased myotube formation. 
Experimental Design: Human primary pericytes were transfected with the same 
expression constructs as in Aim #2 to alter NF-kB activity. Transfected pericytes were 
then co-cultured with C2C12 myoblasts under conditions to promote myoblast proliferation 
or under conditions to promote myoblast differentiation. Proliferation and differentiation 
of myoblasts were then measured under each of these conditions. 
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Brief Results: Pericyte-derived NF-kB activity had a non-cell-autonomous effect on both 
differentiation and proliferation of co-culture myoblasts. When pericytes with enhanced 
NF-kB activity were co-cultured with C2C12 myoblasts under differentiation conditions, 
there was a marked decrease in myotube formation and an increase in myoblast 
proliferation. Inhibition of NF-kB activity in pericytes had no effect on either 
proliferation or differentiation of co-cultured myoblasts.   
 
Summary 
Skeletal muscle has a remarkable capacity to regenerate following injury. The complex 
molecular processes that drive muscle regeneration have received much recent attention, 
but are not fully understood. Although satellite cells are still thought to be the principal 
source of myogenic regenerative cells, we lack a complete understanding of the signals 
that drive satellite cells to differentiate. In this dissertation I present data to support a role 
for NF-kB activation in muscle resident pericytes following a damaging exercise in 
humans (Chapter 3; Aims 1 and 2). Given that recent data have demonstrated that 
interstitially derived NF-kB activity enhances myogenesis in developing muscle (12), it is 
likely to play a similar role during muscle regeneration following damage. Furthermore, 
evidence is emerging that non-satellite, muscle resident cells can contribute to the 
regenerative process via their local signaling influence, as well as their myogenic 
potential (13, 12). However, the relative contribution of these cells to muscle 
regeneration following injury has not yet been defined. In Chapter 4 (Aim 3), I define a 
potential role for these muscle constituents by showing that muscle resident pericytes are 
capable of cell- and non-cell-autonomous effects on myogeneis in an NF-kB dependent 
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manner. The results of this dissertation have stretched our understanding of the molecular 
pathways involved in the muscle regenerative process and may advance our ability to 
treat muscle degenerative diseases such as muscular dystrophies.  
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CHAPTER II 
REVIEW OF LITERATURE 
 
Introduction 
Skeletal muscle is a plastic tissue, capable of repair and regeneration following damage. 
Its capacity to regenerate has been the focus of intense research over the past several 
decades, driven heavily by the need to understand the mechanisms and design treatments 
for muscle degenerative diseases such as Duchenne Muscular Dystrophy. Although 
extensive progress has been made in this area, we still know very little concerning the 
cellular interactions and signaling that result in a healthy muscle regenerative response. 
Furthermore, because of the genetic malleability of animal models and inherent difficulty 
of studying human skeletal muscle, the majority of work conducted to date on the 
mechanisms of muscle regeneration has been done in animals. Thus, there is a specific 
need for translational research in the area of muscle regeneration that focuses on relevant 
and safe human models of muscle damage and regeneration. This review of literature will 
therefore focus on what is currently known about skeletal muscle regeneration, its 
cellular and molecular mechanisms, and how the diverse cellular milieu that constitutes 
skeletal muscle interacts to effectively regenerate damaged muscle. Although much of 
what will be discussed has been developed in animal models, specific attention will be 
paid to the human literature. The review will conclude by discussing relevant models of 
muscle damage in animals and humans, including a review of eccentric contraction-
induced damage, the model employed to study human muscle regenerative signaling in 
this dissertation.  
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Skeletal Muscle Development and Regeneration 
 
Skeletal Muscle Development  
Much of what we know about damage-induced muscle regeneration has been determined 
from studies of embryonic muscle development and cultured myoblasts. Skeletal muscle 
is derived from somites, originating on either side of the neural tube during vertebrate 
development (69). Entry of cells into the myogenic lineage is dependent on signals from 
surrounding tissue and ultimately, the expression of the myogenic regulatory factor 
(MRF) genes. MRFs are a group of basic helix loop helix transcription factors that act as 
master regulatory genes for skeletal muscle differentiation. They include the genes 
MyoD, Myf5, myogenin and MRF4. Genetic knockouts in mice have demonstrated the 
necessity for MyoD and Myf5 activity in the development of muscle (38). Mice null for 
either MyoD or Myf5 develop normally. However, mice null for both MyoD and Myf5 
are born with no skeletal muscle, have no detectable levels of muscle specific mRNAs 
such as myosin heavy chain (MHC), and die shortly after birth from respiratory failure 
(38, 60). Thus, the expression of either MyoD or Myf5 is essential and sufficient for 
skeletal muscle development. Upon expression of the MRFs, MyoD and Myf5, 
proliferative cells withdraw from the cell cycle, commit to the myogenic lineage and 
express the “late” MRFs myogenin and MRF4, which are necessary for terminal 
differentiation into functional myofibers and ultimately, mature muscle (64). Figure 2.1 
depicts the succession of transcriptional activation during muscle development. 
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Figure 2.1: Origin and regulation of satellite cells in skeletal muscle development and 
regeneration. A) In muscle precursor cells, pax3 expression promotes expansion. Commitment 
of mesodermal cells to the myogenic lineage occurs upon expression of MyoD and Myf5. Given 
the correct signals, MyoD/Myf5 expressing cells upregulate myogenin and MRF4, which drive 
expression of muscle specific genes and promotes terminal differentiation. B) A distinct 
population of cells of unknown origin expand during early embryogenesis and express the 
transcription factor Pax7, which is required for satellite cell development and lineage 
determination. Pax7 expressing satellite cells can either upregulate MyoD/Myf5 and differentiate 
into skeletal muscle or can associate with the myofiber in a quiescent, undifferentiated state. 
 
Skeletal Muscle Regeneration  
Muscle regeneration after injury follows similar coordinated patterns of signaling and 
MRF expression as muscle development. It can be broadly characterized by a 
degenerative and subsequent regenerative phase. Mechanical- or chemical-induced 
damage compromises the sarcolemma and can be recognized by the presence of muscle 
specific proteins such as creatine kinase in the blood serum. In response to sarcolemmal 
damage, the initial degenerative phase is thought to first involve the loss of calcium 
homeostasis, thereby activating calcium dependent caspases, which cleave and assist in 
the degradation of damaged myofibrillar proteins (6). This process is followed closely by 
the activation of specific waves of phagocytic inflammatory cells. It has been 
hypothesized that chemotactic factors released by the damaged muscle activate residing 
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and circulating inflammatory cells to initiate the inflammatory response, although there is 
little direct evidence to support this hypothesis. Interleukin-8 (IL-8) is a chemokine that is 
increased in blood serum very early (1-3h) following damaging eccentric exercise, but 
not concentric exercise, making it a likely candidate to signal the initial inflammatory 
response following muscle damage (1). The degenerative period is closely followed and 
somewhat overlapped by a regenerative phase, characterized by the expansion and 
subsequent fusion of myogenic progenitor cells to the damaged myofiber, or to one 
another for de novo muscle fiber formation (13).  
 
Muscle Progenitor Cell Populations 
 
Satellite Cells 
Muscle regeneration following damage is dependent on a pool of undifferentiated muscle 
progenitor cells that are capable of dividing, differentiating and fusing to damaged fibers. 
During development, a subset of Pax7 expressing cells, coined satellite cells, fail to 
differentiate and remain associated with the myofiber in a quiescent state (Figure 2.1B). 
Satellite cells are undifferentiated and similar in appearance to both embryonic and fetal 
myoblasts but express distinct genes during development and thus appear to be 
fundamentally unique to these cell populations (26). They are distinguished from other 
cell types and from myonuclei by their location within the basal lamina surrounding 
myofibers, their high nuclear to cytoplasmic ratio and reduced organelle content. Satellite 
cells play an integral role in regeneration of skeletal muscle following damage. In a 
coordinated and well-characterized fashion, satellite cells become activated, enter a 
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proliferative phase and then fuse to areas of damaged muscle (Figure 2.2A). The 
necessity of satellite cells in regenerative muscle is well-illustrated by the inability of 
pax7 null mice, which lack satellite cells, to effectively regenerate muscle following 
damage (41). As in the developmental stages, the MRFs MyoD, Myf5 and myogenin play 
pivotal roles in the activation and terminal differentiation of satellite cells. Using 
transcriptome analysis, Zhao and Hoffman (76) have perhaps provided the most detailed 
description of the transcriptional profile following muscle injury during 27 regenerative 
periods. Their data indicate a pattern of gene expression for the MRFs and MRF 
associated genes that is similar to muscle development and begins as early as 2-3 hours 
post-injury in mice. In fact, Cooper et al. (17) have shown in a mouse model that both 
MyoD and Myf5 are activated in satellite cells as early as 3 hours post-damage. 
Furthermore, they report that at 12 hours post-damage, the activation of MyoD and Myf5 
are no higher than at 3 hours, indicating the importance of early activation. Figure 2.2B 
details the time course of the stages in regenerative muscle. 
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Figure 2.2: Coordinated muscle regeneration following damage. A) Following muscle 
damage quiescent satellite cells are activated, proliferate, migrate to areas of damage and 
differentiate to repair damaged muscle. B) A time course of satellite cell activation and 
differentiation following damage. 
 
Other Muscle Progenitor Populations 
In addition to the demonstrated regenerative capacity of satellite cells, it is now becoming 
clear that other cell populations are likely involved in limited muscle regeneration. Both 
muscle and non-muscle derived cells have been shown to possess myogenic potential. 
For example, a pioneering study by Ferrari et al. (27) showed that bone marrow derived 
cells can be recruited and differentiated into myofibers following injury. Other groups 
have similarly shown that marrow cells have myogeneic potential and express MRF 
genes at high levels when delivered or co-cultured with murine muscle (18, 37). More 
recently, blood vessel derived pericytes isolated from human biopsy samples showed 
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rates of myogenic differentiation similar to that of satellite cells, both when they were co-
cultured with C2C12 myoblasts or cultured alone under low growth factor conditions (24). 
This finding underscores a potential role for these cells in injury-induced muscle 
regeneration. In support of this assertion, Dellavalle et al. (24) further demonstrated that 
muscle-derived pericytes, when transplanted into dystrophic mice, gave rise to new 
dystophin expressing fibers. Because pericytes isolated from skeletal muscle are likely to 
be contaminated with satellite cells, studies using muscle-derived pericyte cells have been 
criticized. In response to this criticism, Kirillova et al. (40) used a pericyte population 
isolated from bovine retinal tissue to test the myogenic capability of this cell type. Their 
data suggest that retina-derived pericyte cells can spontaneously fuse with preexisting 
myotubes in co-culture. Most recently, pericytes derived from human placental tissue 
have been shown to have myogenic potential and significantly rescue dystrophin 
expression in an mdx mouse model of dystrophy (57).  
 
Thus, there is evidence to support the notion that muscle and non-muscle residing cell 
populations, distinct from satellite cells, are capable of, and likely contributing to 
myogenesis following injury. However, our understanding of the signaling pathways and 
mechanisms that govern that myogenic commitment in vivo is lacking. Furthermore, the 
functional interactions and signaling between these and other muscle residing cell types 
following muscle injury are relatively unknown. Future studies that employ the isolation 
of primary myogenic cells from regenerating muscle via flow cytometry may perhaps 
help to reveal some of these important mechanisms. 
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Inflammatory and Muscle-Residing Cell Signaling 
 
The composition of skeletal muscle can be most accurately described as a heterogeneous 
mix of multi- and mono-nucleate cell types. In addition to the multi-nucleate myofibers, 
several mono-nucleate cells have been identified to both reside in and infiltrate skeletal 
muscle following injury. While we still know relatively little about the functional 
interactions between these distinct cell types, it is clear that they play an integral role in 
the acute response and subsequent regenerative response following damage. 
 
Inflammatory Cells 
Following acute injury, distinct populations of inflammatory cells infiltrate muscle in a 
predictable pattern. Between 2 and 24 hours post-injury, neutrophils respond first 
followed by a wave of phagocytic macrophages at 24-48 hours post-injury. This response 
is closely followed by the invasion of a second wave of non-phagocytic macrophages 
between 48 and 72 hours post-injury (72). Interestingly, the timing of these inflammatory 
cell population waves correlates well to the expression patterns of the myogenenic 
transcription factors (MyoD, Myf5 and myogenin) in MPCs; most notably, the satellite 
cells. Therefore, it has been hypothesized that chemokine signaling between infiltrating 
inflammatory cells and satellite cells plays a key role in the initiation and progression of 
muscle regeneration. For example, in multiple models of muscle injury in rodents, MyoD 
expression in satellite cells has been shown to peak at 48 hours post-injury, coincident 
with the decline in phagocytic macrophages and the increase in the non-phagocytic 
macrophages (43, 52). The effect of inflammatory cell signaling on myogenesis is further 
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illustrated in vitro by the co-culture of specific inflammatory cell populations with C2C12 
myoblasts. When co-cultured with cells of the macrophage lineage, C2C12 myoblast 
proliferation is enhanced and associated with more MyoD positive nuclei (49). More 
recently, several studies have focused on the specific inflammatory cell derived 
chemokines responsible for driving satellite cell proliferation and myogenesis. Some of 
the more well-studied chemokine proteins include moncyte chemoatractant protein-1 
(MCP-1), macrophage inflammatory protein-1α (MIP-1α), macrophage inflammatory 
protein-1β (MIP-1β) and leukemia inhibitory factor (LIF), all of which have been shown 
to affect satellite cell proliferation and myogenesis in vitro and in vivo (73, 74). 
Furthermore, knockout mouse models for several of these chemokines have shown 
compromised muscle regeneration (16, 65). Thus, evidence is accumulating to support a 
central role for inflammatory cell signaling in muscle regeneration following injury.  
 
Other Muscle-Residing Cells 
In addition to infiltrating inflammatory cells, signaling by other muscle residing cell 
types can influence muscle regeneration. A recent investigation by Dahlman et al. (22) 
has demonstrated that stromal fibroblasts can promote myogenesis in developing neo-
natal muscle tissue via nuclear factor-kappaB (NF-kB) dependent nitric oxidide synthase 
(iNOS) signaling. Given the parallels between myogenesis during development and 
following injury, this represents a possible mechanism for enhanced myogenesis 
following injury. A small population of non-phagocytic macrophages has also been 
described to reside in skeletal muscle (51). However, there are limited data available on 
the functional relationship between these residing macrophages and other cells involved 
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in muscle regeneration. It would be logical to assume, given their immediate proximity to 
the muscle fibers, that they may be involved in the signaling of an early inflammatory 
response to injury. Overall, the contributions of non-satellite cells to the muscle 
regenerative process following injury is not very well characterized or understood. 
 
Myofibers 
Given that compromise of the membrane of individual myofibers is observed following 
muscle damage (53), it has been hypothesized that factors released from damaged 
myofibers result in activation of MPCs. Several growth factors that are known to be 
produced and secreted by myofibers including HGF, IGF-1 and FGF have been shown to 
activate satellite cells and suggested to be important in signaling their activation 
following damage (2, 71). However, the ultimate source of these trophic factors 
following damage remains uncertain. Likewise, members of the interleukin (IL) family of 
proteins have been suggested to be released from damaged myofibers and contribute to 
satellite cell activation. Recent work by McKay et al. (50) have shown that IL-6 plays a 
key role in satellite cell activation and proliferation in human muscle, 4 hours following 
ECC-induced damage. Other studies have measured serum concentrations of IL-8 
following both concentric and eccentric exercises (11, 55). Interestingly, IL-8 serum 
concentration is increased only following exercise with an eccentric component (e.g. 
running), leading some to speculate that it may signal be released from damaged 
myofibers to signal the inflammatory response. Although, IL-8 mRNA levels have been 
shown to increase following eccentric exercise (8), the ultimate cellular source (i.e. 
myofiber, satellite cell etc.) of IL-8 has not been determined. However, of particular note, 
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is that both IL-6 and IL-8, in addition to several of the aforementioned growth factors are 
regulated at the mRNA transcript level by activation of the transcription factor Nuclear 
Factor kappa-B (NF-kB). 
 
NF-kB Signaling in Muscle Regeneration and Myogenesis 
 
NF-kB Signaling 
Nuclear Factor kappa-B (NF-kB) belongs to a family of transcription factors consisting of 
5 proteins (p65, c-Rel, RelB, p50 and p52). NF-kB is maintained as a heterodimeric 
protein complex (most commonly p50/p65) that resides in the cytosol of cells in its 
inactive form, held there by its inhibitor protein IkB. It is activated by a well-known 
mechanism involving the phosphorylation of the IK-kinase (IKK) complex. IKK in turn 
phosphylates IkB, resulting in its ubiquitin-dependent degradation and subsequent release 
of NF-kB. Upon its release from IkB, NF-kB translocates to the nucleus where it 
activates transcription of a host of dependent genes.  
 
The degradation of IkB can be mediated by two distinct signaling pathways; the classical 
and alternative pathways. The classical pathway generally refers to the activation of the 
p50/p65 heterodimer. Although there is some evidence that the alternative pathway 
(RelB/p100 heterodimer) is important in muscle function and myogenesis (5), this review 
will deal primarily with the classical pathway, as the majority of research has focused 
here. A schematic of the classical NF-kB signaling pathway is shown in Figure 2.3.  
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Activation of NF-kB is primarily stimulated in response to inflammatory cytokine 
activity including interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-a) (62), in 
addition to growth factors such as insulin like growth factor-1 (IGF-1) and epidermal 
growth factor (EGF) (31). NF-kB, in addition to functioning as a well-studied pro-
inflammatory transcription factor, is also involved in the transcriptional regulation of 
genes associated with developmental processes (22), cell growth and proliferation (7), 
and survival (3). However, this dissertation will focus on its emerging role during skeletal 
muscle differentiation and regeneration. 
 
                    
Figure 2.3: Classical NF-kB signaling pathway 
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NF-kB and Muscle Regeneration 
In muscle, a consensus on the effect of NF-kB on developing and regenerating muscle 
has not been made. However, the majority of evidence supports that the NF-kB signaling 
pathway acts as an inhibitor of myogenesis. Early reports in cultured myoblasts have 
associated differentiation with a decline in NF-kB activation (45). More direct evidence 
indicates that NF-kB activation can both promote the degradation of MyoD and suppress 
the expression of myofibrillar genes (42, 68). In mice, the inhibition of NF-kB activation 
has also been shown to enhance satellite cell activation and facilitate muscle regeneration 
following muscle damage (54).  In contrast, in vitro studies have reported that NF-kB is 
required for differentiation (4, 10). This pro-myogenic effect has been further 
demonstrated in vivo by Dahlman et al. (22), who observed high NF-kB activity in the 
first two weeks of mouse neonatal development, a period of growth associated with high 
levels of myogenesis. Importantly, their subsequent analysis of the localization of NF-kB 
activity showed that the increases in activity originated from muscle-residing stromal 
fibroblasts and not the muscle fibers. Furthermore, they showed that NF-kB activity in 
stromal fibroblasts promoted myoblast fusion via nitric oxide synthase (iNOS) signaling. 
This study provided novel and important insight into the role that cellular 
compartmentalization plays in the molecular signaling of muscle. Future work should 
now be directed towards elucidating this same effect in regenerating adult skeletal 
muscle. 
 
 27	  
Interestingly, there are few reports in humans on the function of NF-kB signaling in the 
regenerative response that follows muscle damage. This is somewhat surprising in light 
of the fact that muscle damage results in a predictable and well-characterized 
inflammatory and oxidative stress response (48, 72), both of which are associated with 
activation of NF-kB (35). The few studies that have measured NF-kB activation 
following what might be considered a damaging exercise have reported either a decrease 
or no change in its activity (12, 25). For example, Durham et al. (25) reported decreased 
NF-kB DNA binding activity via elecromobility shift assay (EMSA) immediately 
following a lower body resistance exercise (eccentric and concentric work). In contrast to 
the previous human work, studies in rodents have demonstrated a clear pattern of NF-kB 
activation following muscle contraction and/or an acute bout of exercise (32, 36). 
Furthermore, treadmill running in rats, which has a strong eccentric, damaging 
component, has been shown to increase NF-kB binding activity, enhance Iκκ 
phosphorylation and increase IL-6 mRNA expression, all of which suggest activation of 
NF-kB (36, 67). Thus, given its well-established role in skeletal muscle myogenesis in 
vitro and in rodents, future studies should focus on a function for NF-kB in the 
regenerative response of human muscle following damage. 
 
Other Signaling Pathways Associated with Muscle Regeneration 
 
PI3k/Akt 
The maintenance of skeletal muscle mass, in addition to being a function of balanced 
protein synthesis and degradation, is also regulated by de novo myogenesis. For example, 
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a hallmark of both sarcopenia (age-related loss of muscle mass) and cachexia (disease-
related loss of muscle mass) is a progressive incapacity of satellite and other progenitor 
cells to repair damaged or degenerative muscle (58, 63). Myogenesis is regulated in 
satellite cells by the transcriptional activation of a group of genes known collectively as 
the myogenic regulatory factors (MRFs). They include the genes MyoD, Myf5, myogenin 
and MRF4. In response to various stimuli, for example, damage caused by strenuous 
exercise, a subset of muscle satellite cells become activated and begin to express MyoD 
and Myf5. These “activated” cells, known as myoblasts, become committed to the 
myogenic lineage and soon thereafter begin expressing myogenin and MRF4. Upon 
expression of these “late” MRF genes, myoblasts migrate to areas of damaged muscle 
and fuse to the damaged muscle fibers. A schematic of this process is provided in Figure 
2.2.  
 
In addition to its well-described regulatory role in the maintenance of mass post-mitotic 
muscle mass, Akt has been implicated to function in myoblasts to regulate myogenesis. 
Early work by Fujio et al. (28) showed that Akt activity promotes both myoblast cell 
cycle withdrawal and cell survival. Subsequent work demonstrated that this regulation 
occurs through phosphorylation of the FOXO1a transcription factor that, when 
manipulated to disallow Akt phosphorylation, remained in the nucleus and prevented 
myoblast differentiation (33). More recent studies have shown that myoblasts lacking Akt 
have a marked decrease in the production of muscle-specific proteins and a reduced 
capacity to differentiate into multinucleated myotubes (59). Further support for the pro-
myogeneic effects of Akt activation has been provided by Kim et al. (39), who used 
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overexpression of a constitutively active Akt to promote muscle regeneration and 
improve measures of muscle function in a dystrophic mouse model. Thus, although the 
developing consensus supports the notion that Akt acts as a pro-myogenic regulator, the 
mechanisms of its action are still unclear. For example, many have speculated that Akt 
promotes myogenesis via the regulation of the MRFs MyoD and myogenin; however, 
there are no data to support this hypothesis to date. 
 
p38 Mitogen Activated Protein Kinase (p38 MAPK)  
Activation of p38 MAPK is considered to be an essential and early event in myogenesis 
in vitro (9) and during early embryonic development (23). It is generally regarded as a 
molecular switch for the activation of myogenesis through multiple mechanisms. One of 
its more well-documented mechanisms of action involves the phosphorylation and 
activation of chromatin remodeling complexes, which facilitate MyoD and myocyte 
enhancer factor (MEF)-2 binding to the myogenin promoter (66). p38 MAPK activation 
has also been shown to enhance MyoD nuclear translocation and muscle specific gene 
transcription (46). Despite its well-established role as a pro-myogenesis factor during 
embryogenesis and in vitro, the role of p38 MAPK activity following injury is less clear. 
For example, myogenic regulatory factor-4 (MRF-4), a member of the MRF family of 
transcription factors, is de-activated following phosphorylation by p38 MAPK, leading to 
transcriptional repression of myogenic genes (70). Moreover, p38 MAPK deficient mice 
display normal muscle regeneration following chemically induced muscle injury (61). 
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Overall, there is strong evidence to support the pro-myogenic requirement of p38 MAPK 
activation in developing muscle. However, in regenerating adult skeletal muscle, the 
limited data available to date are inconclusive. Clearly, more work is needed to 
adequately define a functional requirement for p38 MAPK in muscle regeneration. Future 
studies on the effect of p38 MAPK activation on the myogenic differentiation of non-
muscle derived cells would also be important, as they may perhaps lead to potential 
therapeutic targets for muscle degenerative diseases. 
 
Animal and Human Models of Muscle Damage 
 
To adequately study the mechanisms of skeletal muscle regeneration, an experimental 
model of muscle injury in necessary. Several models of muscle injury have been 
developed in animals, humans and in isolated single muscle fibers, each with distinct 
strengths and weaknesses. 
 
Animal Models 
The injection of myotoxins into animal muscle tissue has been a mainstay for the 
mechanistic study of muscle regeneration for several decades (21, 30). Employed in large 
part due to its reproducibility and convenience, localized myotoxin injection results in 
membrane disruption and lysis of various cells. Within 1 to 3 days, the muscle is 
infiltrated with mononuclear inflammatory cells and de novo myotube formation and 
myogenesis is generally observed within 5 to 6 days post injection. Although effective at 
producing local muscle injury, the unknown effects of the toxin on other cell types, 
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including satellite cells have called into question its physiologic relevance. Consequently, 
other models of muscle damage in animals have been developed. Some of these include 
direct infliction of damage by crushing or freezing. Although not as predictable and 
controlled as myotoxin injection, these methods have been shown to generally result in 
muscle injury and subsequent regeneration (44). Alternatively, though more technically 
difficult, high intensity exercise, specifically exercise with an eccentric component has 
also been shown to be effective at inducing muscle damage in animals, albeit at a much 
lower level than the aforementioned methods (34). 
 
Human Models 
Due primarily to ethical considerations, experimental paradigms of muscle injury in 
humans are much more limited. However, one approach that has exploited a common 
mechanism for normal and transient muscle damage in humans is the induction of muscle 
injury via eccentric exercise. It has been very well documented that eccentric contractions 
do indeed produce muscle damage and subsequent adaptation (15, 29). Damage is evident 
at the ultra-structural level by disrupted sarcomere structure (75), at the cellular level by 
loss of membrane integrity and necrosis (19, 53), and at the functional level by decreases 
in strength and increases in soreness (15). Furthermore, the recovery from eccentric-
induced damage involves a significant regenerative response wherein satellite cells are 
activated and incorporated into damaged fibers (19, 20, 56). Most recently, O’Reilly et al. 
(56) reported an increase in satellite cell number as early as 24h post-eccentric exercise of 
the knee extensors in humans, suggesting that eccentric exercise-induced damage is 
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sufficient to initiate a regenerative response and represents an apt model for the study of 
regenerative pathways in humans. 
 
To date, multiple variations of the eccentric exercise paradigm have been developed. Of 
these, perhaps the most frequently used is injury of the elbow flexors. Our laboratory has 
also pioneered the use of a modified preacher curl bench, wherein an extended lever arm 
provides the researcher with the ability to force the arm into extension as the study 
participant maximally resists with the elbow flexors. These methods have been repeatedly 
shown to result in muscle damage as indicated by prolonged strength loss, soreness and 
increased serum CK and myoglobin (indirect markers of muscle damage) (15). The knee 
flexors have also been used frequently as the target of muscle damage studies, likely 
because they are larger and easier to extract tissue from via a biopsy. Similarly, eccentric 
contraction-induced damage of the knee flexors has been shown to produce robust and 
repeatable changes in the direct (sarcomere disruption) and indirect markers of muscle 
damage (14, 47, 56). The following investigations presented in this dissertation on the 
molecular changes following muscle damage have used this model to effectively induce 
transient muscle damage. Studies employing models such as these will be important in 
determining the underlying mechanisms and molecular signaling responsible for the 
muscle regenerative response in humans to damage. 
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Conclusion 
 
Muscle regeneration has, for many decades, been thought to occur exclusively via the 
action of muscle-resident satellite cells (SC). However, evidence has recently emerged 
that non-satellite muscle- and non-muscle- resident cells may play a role in the 
regenerative response and may, in fact, contribute both directly (myogenic 
differentiation) and indirectly (signal myogenic differentiation) to in vivo muscle repair. 
However, the extent to which this occurs in human muscle is unknown, as are the 
signaling pathways responsible for driving their myogenic differentiation. In the 
following studies, I have used an eccentric contraction model of muscle damage (Chapter 
3) and an in vitro model of myogenesis (Chapter 4) to show that micro-vessel associated 
pericyte cells (both muscle and non-muscle derived) may influence muscle differentiation 
following damage via activation of the NF-kB signaling pathway. The results of these 
studies have provided insight into the mechanisms that may drive myogenic commitment 
and will have implications for potential molecular targets to enhance muscle regenerative 
action in satellite and non-satellite muscle progenitor cells. 
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CHAPTER III 
ACTIVATION OF NUCLEAR FACTOR-KappaB FOLLOWING MUSCLE 
ECCENTRIC CONTRACTIONS IN HUMANS IS LOCALIZED PRIMARILY TO 
SKELETAL MUSCLE RESIDING PERICYTES 
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Introduction 
 
Skeletal muscle has a dynamic capacity to adapt following changes in functional demand 
or damage. Its adaptive response, which is dependant on the activation and regenerative 
action of muscle progenitor cells (1), is essential for the maintenance of muscle mass and, 
when dysregulated as a result of disease or aging (2, 3), can lead to significant losses in 
functional capacity and increased mortality (4). The activation of muscle progenitor cells, 
most notably satellite cells, likely involves complex signaling between the myofibers, 
their interstitial environment and other systemic factors. Significant advances in the 
understanding of these signaling relationships and mechanisms have been made in recent 
years. For example, smooth muscle and fibroblastic cell derived signaling was shown to 
influence activation and self-renewal of satellite cells (5). Likewise, growth factors such 
as fibroblast growth factor (FGF) (6), insulin-like growth factor 1 (IGF-1) (7) and 
hepatocyte growth factor (HGF) (8) have been shown to influence satellite cell activation 
and muscle regeneration, although their cellular origins during in vivo muscle 
regeneration are largely unknown. Despite these advances, there exists a significant gap 
in our understanding of these relationships in human skeletal muscle, as the majority of 
these studies have been done in rodent or cell models, which may not completely 
recapitulate the regenerative events in human muscle (9). Thus, the further 
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characterization of the molecular mechanisms that drive the regenerative and adaptive 
response in human muscle is imperative to enhance our current modes of therapy in 
diseased or aged muscle.  
 
The performance of eccentric contractions (EC) has been shown to safely and effectively 
induce transient muscle injury that results in a well-characterized regenerative response 
involving the activation and proliferation of muscle satellite cells (10-12). We, and others 
have used this model in humans to evaluate changes in global gene expression and have 
identified changes in the transcriptional activity of genes associated with inflammation, 
protein synthesis, extracellular matrix remodeling and myogenesis (13-16). However, due 
perhaps to the invasive nature of extracting muscle tissue from humans or the associated 
cost of commercial microarray platforms, subject sample size in these studies has been 
small. For example, Chen et al. (13) report gene expression changes via microarray 
analysis following EC in 3 male subjects. Likewise, others have data using similar 
methods in 3 (15), 6 (14) and 4 (16) subjects. Thus, while these studies have made 
significant contributions in ascertaining some of the more highly dysregulated genes 
following EC (13, 15, 16), their small sample sizes have precluded a network analysis, 
wherein detection of moderate changes (not likely to be seen with a small sample) in 
multiple or groups of genes enhances the ability to identify important biological pathways 
involved in muscle adaptation and regeneration after EC.  
 
Therefore, the present study was undertaken with the primary objective of further 
characterizing the early molecular response to EC in humans by: 1) conducting a well 
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powered, genome wide screen and systems level analysis at the transcriptional level and 
2) using these data to derive testable hypotheses for follow up analyses. We expected that 
our approach would provide a novel transcriptomic profile highlighting potential 
pathways and networks that may govern early changes suggestive of muscle regeneration 
and adaptation and that our follow-up analyses would confirm these findings.  
 
In the following study we provide support for the transcriptional activation of both 
previously reported and novel genes following EC in humans. More importantly, our 
follow up analyses offer compelling evidence for the activation of the NF-kB 
transcription factor complex in human skeletal muscle shortly following EC and the 
localization of its activity primarily to muscle residing pericyte cells. 
 
Methodology 
 
Subjects: Thirty-five healthy male subjects (20.9 ± 0.5yrs, 178.9 ± 1.2cm and 80.6 ± 
2.9kg) volunteered for this study and had muscle biopsies sampled from the control (non-
EC) and EC legs. All subjects signed a written informed consent document approved by 
the University of Massachusetts Amherst Institutional Review Board. All study 
procedures conformed to the standards outlined in the Declaration of Helsinki. Subjects 
had no prior history of musculoskeletal injury of the lower extremity and were willing to 
refrain from participating in new physical activities or taking oral or topical analgesics 
for the duration of the study. Subjects were excluded if they had been involved in a 
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strength-training program in the past 6 months or routinely lifted heavy objects or 
engaged in activity with a heavy eccentric component.  
 
Study Design: The study consisted of 7 visits over the course of 1 week. Subjects 
reported to the laboratory for their first visit fasted and had their blood drawn for baseline 
creatine kinase (CK) activity measurements. The blood draw was followed by an 
orientation to the Biodex System 4 dynamometer (Biodex Medical Systems, Shirley, NY) 
and subsequent baseline strength tests on a randomized (dominant vs. non-dominant) leg. 
The following day (24 h after visit 1), subjects once again reported to the laboratory in a 
fasted state (12 h). Upon arrival they were provided a standardized breakfast consisting of 
400 kcal (approximately 55% carbohydrate, 30% fat and 15% protein). Subjects then 
performed a baseline soreness/pain assessment using a visual analog scale (VAS). This 
was followed by a muscle strength assessment and the eccentric contraction protocol. 
Muscle strength was assessed again immediately following the contractions. Three hours 
after the completion of the contraction regimen, a muscle biopsy was taken from the 
vastus lateralis of both legs. The non-eccentrically contracted leg was designated the 
control; the eccentrically contracted leg was designated as EC. Muscle strength and 
soreness were then assessed every 24 ± 2 h for 120 h on the EC leg; CK levels were also 
measured every 24 h during the same period. 
 
Contraction Protocol: We used a contraction protocol similar to that developed and used 
previously by others to induce muscle damage (16). Subjects completed 100 maximal 
eccentric contractions using a Biodex isokinetic dynamometer. Subjects were seated in 
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the dynamometer and a randomized (dominant vs. non-dominant) leg was strapped to the 
lever arm. Subjects were first asked to extend the lever arm as far as possible. This 
position was designated as 0 degrees of flexion. From this point of reference, the 
dynamometer limits were set to exercise the subject through a range of motion of 35 
degrees of knee flexion to the subject’s maximal flexion angle. Total range of motion 
averaged about seventy-five degrees. The protocol consisted of 10 sets of 10 repetitions 
with 10 s rests between repetitions and 1min rests between sets. For each repetition, 
subjects were instructed to maximally extend or “kick” as the dynamometer moved from 
30 degrees of knee flexion to the subject’s maximal flexion angle at 30 degrees per 
second. Following each repetition, the dynamometer returned the leg to 30 degrees of 
knee flexion.  
 
Muscle Biopsy: Percutaneous needle biopsies of both the EC and non-EC vastus lateralis 
muscle were obtained 3 h following the eccentric exercise. Under local anesthesia 
(Lidocaine), a small incision was made into the skin and fascia, and the biopsy needle 
was inserted into the muscle. A small core of tissue (~100mg) was withdrawn and was 
immediately frozen in liquid nitrogen. The tissue was then stored at -80°C until it was 
used for analyses. 
 
Knee Extension Strength Testing: A measure of maximal isometric strength of the knee 
extensor muscles was assessed on the Biodex dynamometer at an angle of 70 degrees of 
flexion. Subjects completed three 3 s isometric contractions with a 1 min rest between 
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trials. Peak isometric torque values were defined as the average of the highest attainable 
values for each of the 3 trials.  
 
Muscle Soreness: Soreness was evaluated using a visual analog scale (VAS); a 100mm 
line with 0mm indicating “no pain” and 100mm indicating “unbearable pain.” Subjects 
marked the scale with a single vertical line following two hip/knee flexion and extensions 
(sitting and rising from a chair). The distance from the left end of the scale to the mark 
was taken as the soreness level. All subjects provided a pre-EC VAS evaluation. If the 
baseline VAS score was determined to be greater than 10mm, the subject was asked to 
return two or more days later to allow any soreness to dissipate. 
 
Total RNA Isolation and Microarray Hybridization: Total RNA from EC and control 
samples of 35 subjects were extracted using the standard TRIzol (Invitrogen, Carlsbad, 
CA) method. mRNA was then isolated using the Oligotex mRNA Midi kit (Qiagen, 
Valencia, CA) according to the manufacturer’s instructions. Double stranded cDNA was 
created using the Ovation Pico WTA system (NuGEN, San Carlos, CA) according to the 
manufacturer’s instructions. Cy3 labeling and hybridization on to an Agilent Whole 
Genome Microarray (Agilent, Santa Clara, CA) were done at Gene Logic Inc. 
(Gaithersburg, MD) according to the manufacturer’s specifications.  
 
qRT-PCR Analysis: 100ng of total RNA from each sample was reverse transcribed using 
a cloned murine leukemia virus reverse transcriptase (Fermentas, Glen Burnie, MD) 
according to the manufacturer’s instructions. The relative levels of Ikba, ICAM1, 
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TNFRSF1A and CEBPD were measured by quantitative real-time (qRT) PCR.  ABgene 
Absolute qPCR SYBR Green Master Mix (ABgene, Surrey, UK) with ROX dye was 
used for all PCR protocols.  qRT-PCR reactions were performed in 96-well plates with 
all cDNA samples from both EC and control legs run in triplicate for each gene of 
interest along with no template controls. The average Ct (cycle threshold) value for 
triplicate samples was used for data analysis. Ct values were directly related to 
fluorescence of the respective SYBR-green probe after 40 cycles of amplification on a 
MX3000p Real-Time PCR System (Stratagene, La Jolla, CA). At the end of each 
reaction, a melting curve analysis was run to identify possible primer dimers. The results 
of the melting curve analysis was confirmed, and appropriate product size determined via 
2% Agarose gel electrophoresis with ethidium bromide staining. 
Table 3.1: qRT-PCR primers 
 
                 
Differences in relative gene expression were determined by the ΔΔCT method.  Values 
were normalized to expression of Beta-2-Microglobulin (B2M), an internal control, 
previously validated for eccentric exercise studies (18). Forward and reverse primers 
(Integrated DNA Technologies, Coralville, IA) of all genes of interest were tested for 
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efficiency. All primers had efficiencies between 95 and 105% and thus were deemed 
appropriate to assess relative expression via the ΔΔCT method. Primer sequences are 
presented in Table 1. 
 
ELISA-based NF-kB Activation Assay: Due to limited tissue, NF-kB activation analyses 
(ELISA and immunohistochemistry) were performed on EC and control biopsy samples 
of a subset of 15 subjects. Nuclear extracts were prepared by homogenizing tissue 
samples in a low salt lysis buffer (10mM HEPES pH 7.6, 10mM KCL, 1.5mM MgCl2, 
0.1mM EDTA, 0.1 mM DTT, 0.5 M PMSF, 50µl protease inhibitor cocktail and 
0.5mg/ml benzamidine). Homogenized tissue was then subjected to 2 cycles of 
freeze/thaw using an ethanol/dry ice freeze bath and a 37°C water bath. Samples were 
then vortexed and cetrifuged at 3000 RPM for 3 min at 4°C. The supernatents (cytosolic 
protein) were then pipetted off and the nuclear pellet was re-suspended in high salt buffer 
(20mM HEPES pH 7.6, 420mM NaCL, 1mM EDTA, 25% glycerol, 1 mM DTT and 5µl 
protease inhibitor cocktail). The samples were then incubated on ice for 30 min after 
which they were centrifuged at 13,000 RPM for 5 min at 4°C. The supernatant, 
containing the nuclear protein fraction was pipetted off and stored and quantified. A 
standard BCA assay (Pierce, Rockford, IL) was used to quantify nuclear protein. NF-kB 
activation was determined using nuclear extracts and an ELISA-based TransAM NF-kB 
p65 assay kit (Active Motif, Carlsbad, CA) according to the manufacturer’s instructions. 
Briefly, 5µg of nuclear extract were added to wells coated with a consensus binding 
sequence for NF-kB (5’-GGGACTTTCC-3’) and incubated for 1h at room temperature. 
Wells were then washed and a primary antibody directed at the p65 subunit was added 
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and left to incubate for 1h. This was followed by treatment of all wells with a secondary 
antibody conjugated to horseradish peroxidase (HRP). A subsequent colorimetric reaction 
was initiated with the addition of a developing solution for 5 min followed by the 
application of a stop solution.  The absorbance of the plate was then read at 450nm on a 
multi-well microplate reader (FLUOstar Optima, BMG LABTECH). Wild type and 
mutated consensus oligonucleotides were used as competitors for NF-kB binding to 
ensure specificity of the reaction as per the manufacturer’s instructions. All samples were 
run in duplicate and the average value was used for data analysis. 
 
Immunohistochemistry (IHC): 10µm cross sections of muscle biopsy tissue samples from 
EC and control legs of the same 15 subjects were generated on a MICROM HM 505E 
cryostat at -25°C (Richard Allan Scientific, Kalamazoo, MI). Samples were mounted to 
Superfrost slides (Fisher Scientific) and air-dried for 30 min. Sections were re-hydrated 
with 1XPBS with 0.01% N2Na for 5 min and blocked in 5% BSA (Invitrogen, Carlsbad, 
CA) for 15 min at room temperature. Sections were then incubated in the appropriate 
primary antibodies, diluted 1:100 in 5% BSA for 1h at 37°C. Following incubation, 
sections were washed 3 times in 1X PBS for 5 min and blocked again in 5% BSA. 
Sections were then incubated in appropriate secondary antibodies and 49,6-diamidino-2-
phenylindole (DAPI) (Sigma, USA) or Topro3 (for confocal microscopy) (Invitrogen, 
USA) for 30 min at 37°C, washed in PBS and mounted. Stained slides were imaged on 
either a Nikon model TE-2000 inverted microscope and a SPOT Insight imaging color 
camera (Diagnostic Instruments, Sterling Heights, MI), or a Zeiss 510 META confocal 
laser scanning microscope. The following primary antibodies were used: NF-kB-p65 
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(polyclonal, 1:100; Abcam, Cambridge, MA), NG2 (monoclonal, 1:100; Abcam, 
Cambridge, MA), dystrophin (monoclonal, Mandra-1 clone, 1:100; Developmental 
Studies Hybridoma Bank, Iowa City, IA), Alkaline Phosphatase (ALP) (monoclonal, 
1:100; Developmental Studies Hybridoma Bank, Iowa City, IA), Pax7 (monoclonal, 1:50; 
Developmental Studies Hybridoma Bank, Iowa City, IA). Secondary antibodies used 
were: Alexa-Fluor 488 anti-rabbit (Invitrogen, Carlsbad, CA) and DyLight 549 anti-
mouse (Jackson ImmunoResearch Laboratories, West Grove, PA). To demonstrate 
specificity of the p65 polyclonal antibody, antigen competition was carried out by pre-
incubating anti-p65 overnight with either p65 (Abcam, Cambridge, MA) or a control 
peptide at a concentration of 40 µg/ml. Staining for monoclonal antibodies was verified 
using sections null for primary antibody. 
 
Confocal Microscopy: Confocal microscopy was performed using a Zeiss 510 META 
confocal laser scanning microscope and images were collected using the LSM image 
acquisition software. EC and control muscle sections were imaged at the same 
magnification and microscope settings for analysis of signal intensity using a 40x oil 
immersion objective. Control muscles were imaged first and gain scan speed and offset 
were optimized for each channel. EC samples were imaged at the same settings as control 
samples.  A 4µm stack with a Z interval of 0.5µm was scanned through the center of each 
section.  
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Data Analyses: All statistical analyses were computed using a SAS statistical software 
package (V9.2; SAS Institute, Cary, NC), with expression profiling data computed using 
Partek Genomics Suite (V6.5; Partek Incorporated, St. Louis, MO).  
 
Muscle Function.  Muscle strength, CK and soreness were analyzed with a repeated 
measures analysis of variance (ANOVA) and, when appropriate, Tukey’s post-hoc 
analysis was performed. CK data were not normally distributed and were log transformed 
prior to performing the ANOVA. Significance was set a priori at <0.05. 
 
Microarray. Probe set means from microarrays were generated from the PLIER algorithm 
(typically 6 iterations) in Expression Console (Affymetrix Inc., Santa Clara, CA) and 
imported into Partek Genomics Suite software for statistical analysis. PLIER (Probe 
Logarithmic Intensity Error) is a model-based signal estimator beneficial to multi-array 
estimations. Data were log2 transformed and then analyzed by analysis of covariance 
(ANCOVA) using age and body mass index as covariates. The data outputs were 
stringently filtered on the basis of p-value (p<0.007). Gene function and network analysis 
was performed using Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems, 
Redwood City, CA). IPA functional analysis was used to identify the molecular and 
cellular functions of the dysregulated gene set. Genes that met p<0.007 and were 
associated with molecular and cellular functions in the Ingenuity Pathways Knowledge 
Base were considered for further analysis.  Fischer’s exact test was used to calculate a p-
value determining the probability that each molecular and cellular function assigned to 
that data set was due to chance alone. Genes were classified in each set by function. The 
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genes involved in the functions sets of interest were further screened. Differentially 
expressed genes were then mapped to their corresponding genes in the Ingenuity 
Pathways Knowledge Base. These genes were then overlaid onto a global molecular 
network developed from information contained in the Ingenuity Pathways Knowledge 
Base. Networks of these genes were algorithmically generated based on their 
connectivity. The IPA score is a negative log of the p-value for each network. 
 
Immunofluorescent Analyses. Quantification of all immnofluorescent images was made 
using three randomly acquired fields from 15 subjects under both the control and EC 
conditions. Images were taken with a 40X objective to ensure accurate identification of 
nuclei origin (myonuclei or non-myonuclei) and co-localization status. At this 
magnification, approximately 8-10 myofibers per field were analyzed, corresponding to 
roughly 24-30 myofibers and 180 total nuclei per subject per condition (control and EC).   
 
For our initial confocal-based quantification of p65 nuclear localization, triple immuno-
staining, with antibodies against dystrophin, p65 and Topro3 for nuclei were used. The 3 
channels (dystrophin, p65, Topro3) from each stack were merged to determine the 
myofiber boundary. Images were analyzed using Zeiss LSM software. Nuclei with a mass 
center inside the dystrophin ring were considered myonuclei, and nuclei with their mass 
center outside of the dystrophin ring were considered non-myonuclei. The number of 
p65+/Topro3+ myonuclei and non-myonuclei were counted and expressed as a percentage 
of total myonuclei and non-myonuclei, respectively in both control and EC samples for 
each subject. For each stack, the determination of p65+/Topro3+ nuclei was made based 
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on the persistence of co-localization through the entire stack (8 slices). To further assess 
the specific cellular compartment of NF-kB activation, we performed IHC using two 
commonly applied pericyte markers: NG2 proteoglycan (NG2) and alkaline phosphatase 
(ALP), and Pax7 for satellite cells. Images were analyzed using Metamorph software 
(Molecular Devices, Downington, PA). P65+ nuclei (p65+/DAPI+) that stained positive for 
NG2, ALP or Pax7 were counted and expressed as a percentage of total p65+ nuclei in 
each condition for each subject. To be considered as a Pax7+ cell, Pax7 had to co-localize 
to the nucleus.  immunofluorescent enumerations were carried out by the same 
investigator, who was blinded to the condition (EC or control). Data were analyzed using 
a paired Student’s t-test with a SAS statistical software package. Significance was set a 
priori at p<0.05.  
 
Results 
 
Muscle biopsy samples from 35 subjects were analyzed by microarray to examine 
differentially expressed genes 3 h following EC. Of the 35 subjects, 30 had sufficient 
mRNA yield to perform subsequent qRT-PCR confirmational analysis and 15 of the 35 
subjects had sufficient tissue for immunohistochemical (IHC) and nuclear protein extract 
(transcription factor ELISA) analyses. Data for the indirect markers of muscle damage 
are presented for both the whole- (n=35) and sub-cohorts (n=15) to demonstrate that the 
sub-cohort of 15 subjects had similar levels of muscle injury and were representative of 
the larger whole cohort. 
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Indirect markers of muscle damage: Decreased muscle strength, elevated creatine kinase 
(CK) activity and elevated muscle soreness following EC indirectly indicated a moderate 
level of muscle damage in both subject cohorts. Overall, mean muscle strength in both 
the whole- and sub-cohorts was significantly reduced from baseline levels following EC 
as indicated by a significant main effect of time (p<0.01) (Figure 3.1A). Post-hoc 
analysis showed lower strength levels compared to the baseline strength level at all time 
points post-EC except for 120 h post-EC. There were no differences between the cohorts. 
Mean serum CK activity levels were significantly (p<0.01) elevated from baseline after 
EC (Figure 3.1B) and demonstrated large variability (62-20,078 U⋅L-1 at 120 h post-EC), 
driven primarily by two high responding subjects. Post hoc analysis showed that CK 
activity was significantly elevated at 24, 48 and 72 h following EC compared to baseline 
in both cohorts. There were no significant differences between the cohorts for CK 
activity. Muscle soreness was significantly elevated from baseline after EC in both 
cohorts as indicated by a significant main effect of time (p<0.01) (Figure 3.1C). Post-hoc 
analysis showed elevated soreness levels in both cohorts compared to the baseline level at 
all time points except for 120 h post-EC. There were no significant differences between 
the two cohorts at any time point. 
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Figure 3.1: Eccentric contractions (EC) result in muscle damage. A) Mean isometric 
strength pre-, post- and for 120 h following EC in the whole cohort (n=35) and the sub-
cohort (n=15), whose tissue was used for subsequent IHC and ELISA analyses. B) Mean 
serum CK activity pre-ECC and every 24 h for 120 h following EC in both cohorts.  C) 
Mean muscle soreness pre-ECC and every 24 h for 120 h following EC in both cohorts. 
Data are mean ± SE. * indicates significant difference from pre-ECC levels for both 
cohorts (p<0.05).   
 
Global gene expression and molecular network analysis implicate NF-κb signaling 
following EC: To assess transcriptional changes in response to EC, we compared 
expression profiles in the muscle biopsies obtained from the EC leg vs. control (non-EC) 
leg. For our network level analysis, we chose to use a p value cutoff of p<0.007 as our 
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inclusion criteria, rather than fold change, to adequately represent small, potentially 
important transcriptional changes. Significantly dysregulated genes were analyzed by 
IPA software (Ingenuity Systems) to assess functional pathways and associated genes 
that are modified as a result of eccentric contractions. IPA analysis revealed multiple high 
scoring gene networks with relevant functions relating to inflammatory and immunologic 
response, cell growth and proliferation and cell signaling. We noted that the transcription 
factor nuclear factor-kappaB (NF-kB) was highlighted in several of these networks and 
therefore asked IPA to build a network based on known associations between NF-kB and 
the differentially regulated genes in our data set. Presented in Table 3.2 is a list of 
transcripts that were altered as a result of EC and identified by IPA as having a known 
association with the NF-kB transcription factor complex. Collectively, the network level 
analyses suggested that activation of NF-kB may be an important molecular response to 
EC.    
 
qRT-PCR analysis confirms select genes: To verify microarray data, we chose to confirm, 
via qRT-PCR, 3 of the more modestly altered transcripts that showed up in our NF-kB 
networks. These transcripts included: nuclear factor of kappa light polypeptide gene 
enhancer in B-cells inhibitor, alpha (NFKBIA, also known as IkBa), inter-cellular 
adhesion molecule 1 (ICAM1) and CCAAT/enhancer-binding protein, delta (CEBPD). 
We performed qRT-PCR on samples from the EC and control legs of 30 subjects and 
expression was normalized to our housekeeping gene B2M. Figure 3.2 shows that gene 
expression changes, as measured by qRT-PCR were similar to the changes measured by 
the microarray, demonstrating its general reliability in our well-powered sample. 
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Table 3.2: NF-kB-related transcripts that were altered as a result of eccentric 
contractions 
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Table 3.2 (continued) 
 
 
                     
Figure 3.2: qRT-PCR confirmation of a subset of differentially regulated genes from the 
microarray experiment. Data are presented as mean fold change compared to the control 
(non-eccentrically exercised) leg. All PCR was significantly different at p<0.01. Dotted 
line indicates control level (no change). Data are mean ± SE. n=35 for microarray, n=30 
for qRT-PCR. 
 
Activation of NF-kB following EC: To follow up on the observations made by our 
network analysis, we further hypothesized that NF-kB was activated following EC. By 
transcription factor ELISA analysis, we found that there was a significant (p=0.018) 1.6 
fold increase in NF-kB DNA binding activity in muscle samples from the EC vs. the non-
EC control leg (Figure 3.3A). To further confirm this finding and to gather additional 
information on the location of NF-kB activity, we performed immunofluorescence and 
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confocal microscopy on serial muscle sections of EC and control samples using 
antibodies against the p65 subunit of NF-kB, dystrophin and Topro3. This allowed us to 
measure the localization of p65 to individual nuclei (p65+/Topro3+) as an indirect 
measure of NF-kB activation. To determine whether NF-kB activity was localized to 
nuclei within myofibers (myonuclei) or in the interstitial spaces, we co-stained sections 
with an antibody against dystrophin to distinguish the myofiber boundary. Confocal 
imaging of our stained sections revealed a p65 signal with intense foci localized outside 
of the myofiber boundary as well as a more diffuse pattern of expression within the 
myofiber (Figure 3.3C). The absence of the p65 signal, particularly at defined interstial 
foci, in the presence of the peptide used for immunization, demonstrates specificity of the 
antibody (Figure 3.3B). Quantification of p65+ nuclei showed a significantly (p=0.039) 
greater percentage of non-myonuclei that were p65+ in the EC leg (24%) compared to the 
control leg (13%) (Figure 3C and D). Overall, increases in p65+ nuclei in the EC vs. 
control leg were consistent with the DNA binding results. Interestingly, we found that, in 
general, expression of p65 was very low within individual myofibers (inside the 
dystrophin ring) and that localization of p65 to myonuclei was a rare occurrence.  
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Figure 3.3: Activation of NF-kB 3 h following eccentric contractions (EC). A) NF-kB 
(p65) activity measured in EC and control nuclear extracts by an ELISA-based DNA 
binding assay. Data are presented in arbitrary absorbance units (450nm). n=15. Data are 
means ± SEM. B) Specificity of the p65 antibody is confirmed by an antigen competition 
experiment. Confocal images of 10μm serial sections of an EC muscle sample using 
antibodies against p65 (green) in the presence of a control peptide (left panel) or the p65-
derived peptide (right panel), dystrophin (blue), and nuclei (topro=red). C) Confocal 
images of triple stained 10μm sections from representative EC and control samples for 
dystrophin (blue), the p-65 subunit of NF-kB (green) and nuclei (topro=red). Arrows 
indicate nuclei that were determined to be p65 positive (p65+/topro3+). White square in 
the EC image denotes the boundaries of the inset image. Arrowhead in the inset image 
indicates potential location of microvessel. D) p65+/topro3+ myonuclei and non-
myonuclei expressed as a percentage of total myonuclei and non-myonuclei. n=15. * 
indicates significant difference (p<0.05) between control and EC muscle samples. 
 
NF-kB activation in NG2 and ALP positive cells, but not Pax7 positive cells: Our initial 
confocal analysis indicated that the cellular origin of NF-kB activity (p65+/Topro3+) was 
 59	  
localized to the interstitial spaces between fibers. Furthermore, it was noted that a high 
number of these p65+/Topro3+ nuclei were positioned adjacent to, or nearby, what we 
perceived to be potential sites of microvasculature, as indicated by a tubular p65 staining 
pattern (arrow in Figure 3.3C inset image) between fibers. This suspicion led us to 
hypothesize that NF-kB was localized to the nuclei of cells adjacent to, or associated with 
the microvasculature. Thus, we co-stained serial muscle sections with markers of vessel-
associated pericyte cells (NG2, ALP) and satellite cells (Pax7), as the latter have been 
commonly observed in close proximity to capillaries (19). NG2 is a reliable pericyte 
marker that has been used frequently to discriminate pericytes in a variety of different 
tissues and has also been shown to effectively differentiate between pericyte and 
endothelial cells (20). Similarly, ALP has been used previously as a pericyte marker, 
specifically in muscle tissue (21). Co-staining with these markers revealed that both NG2 
and ALP co-localized to 69% and 64% of p65+/DAPI+ nuclei, respectively (Figure 3.4A, 
B and D). In contrast, Pax7 co-localized to only 1% of p65+/DAPI+ nuclei (Figure 3.4C 
and D). These data suggest that pericyte cells and not satellite cells are a primary source 
of increased NF-kB activity in muscle following eccentric contractions.  
 
Because eccentric contractions induce a degree of skeletal muscle damage and result in a 
well-studied muscle progenitor cell response (10, 22, 23), we were further interested in 
determining whether there were changes in the relative number of satellite cells 3 h 
following EC. We found that approximately 5% of total nuclei stained positive for Pax7 
and that there were no differences between EC and control muscle for total satellite cell 
number (Figure 3.4F). This finding is consistent with previous reports, both in terms of 
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the relative number, and the absence of significant numerical changes at approximately 3 
h post-EC in human muscle (10, 12). We were also interested in performing a preliminary 
quantification of pericyte number in human skeletal muscle under the control and EC 
conditions, as there are currently no data on pericyte number in human skeletal muscle. 
By averaging the mean number of NG2+ and ALP+ cells in both conditions, we found no 
changes in the relative number of pericyte cells following EC (Figure 3.4E). 
Interestingly, our enumerations indicated that roughly 7% of nuclei (in both conditions) 
stained positive for pericyte markers. Further analyses, for example, co-staining with 
multiple pericyte markers and subsequent quantification of double labeled cells will be 
important in more definitively ascertaining pericyte cell population in humans skeletal 
muscle.  
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Figure 3.4: Localization of NF-kB to pericytes and not satellite cells 3 h following 
eccentric contractions (EC). A) Immunofluorescent images of a triple stained 10μm 
section from an EC sample for DAPI (blue), the p65 subunit of NF-kB (green) and NG2 
(red). Arrow indicates nucleus that has been determined to co-localize with NF-kB 
(p65+/DAPI+) and stain positive for NG2. B) Immunofluorescent images of a triple 
stained 10μm section from an EC sample for DAPI (blue), the p65 subunit of NF-kB 
(green) and alkaline phosphatase (ALP) (red). Arrow indicates nucleus that has been 
determined to co-localize with NF-kB (p65+/DAPI+) and stain positive for ALP. C) 
Immunofluorescent images of a triple stained 10μm section from an EC sample for DAPI 
(blue), the p65 subunit of NF-kB (green) and Pax7 (red). Arrow indicates a Pax7+ cell 
that does not co-localize with p65. D) Relative number of NG2, ALP and Pax7 positive 
cells that were p65+/DAPI+, reported as a percentage of total myonuclei per field. E) 
Relative number of cells determined to be satellite cells, based on Pax7 staining in 
control and EC muscle sections. F) Relative number of cells determined to be pericytes, 
based on NG2 and ALP staining in control and EC muscle sections. Dotted lines in 
merged images denote the approximate myofiber boundary based on phase contrast 
images. Scale bar = 10µm 
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Discussion 
 
The primary objective of this study was to uncover potentially important gene groups 
and/or molecular networks that govern the early response (3 h post) to EC in humans. We 
positioned ourselves to take a systems approach by using whole genome analysis in a 
well-powered sample of human subjects following EC. Our network analysis led us to 
identify the involvement of NF-kB activation in the early response of muscle to EC. 
Moreover, to further understand the potential impact that NF-kB signaling may have in 
this early response, we have also localized its activity primarily to muscle-residing 
pericyte cells.   
  
Our finding of increased NF-kB activation following EC was supported by evidence from 
both DNA binding and immunohistochemical experiments. We became interested in NF-
kB activation when our network analysis identified several significant associations 
between many of our differentially expressed genes and activation of the NF-kB 
transcription factor complex. Most notably, we observed significant, and in some cases 
large, alterations in mRNA expression of cytokines, growth factors, transcription factors 
and membrane receptors that have been shown to function both upstream and 
downstream of NF-kB activation. To our knowledge, we are the first to demonstrate an 
increase in NF-kB activity following EC. In fact, there are very few reports in humans on 
the effects of exercise or muscle contraction (concentric or eccentric) on NF-kB 
activation in muscle tissue. This is somewhat surprising in light of the fact that EC results 
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in a predictable and well-characterized inflammatory and oxidative stress response (24, 
25), both of which are associated with activation of NF-kB (26). The few studies that 
have measured NF-kB activation in human muscle following an exercise have done so 
subsequent to acute bouts of resistance or endurance type exercise and have reported 
either an increase (27) or no change in its activity (28). However, it must be noted that 
the two referenced studies differed from the current study in the mode of exercise and the 
timing of tissue extraction, making a direct comparison difficult. Perhaps most relevant to 
our data, Durham et al. (28) reported decreased NF-kB DNA binding activity via 
electrophoretic mobility shift assay immediately following a lower body resistance 
exercise (eccentric and concentric work). Interestingly, they also provide data 1 h post-
exercise that showed a return of NF-kB DNA binding activity back to basal levels. Given 
our results of increased NF-kB activity 3 h post-EC, we speculate that perhaps NF-kB 
activation is decreased in the initial moments post-exercise and increased in the 
subsequent hours of recovery. In contrast to the previous human work, but consistent 
with our data, studies in rodents have demonstrated a clear pattern of NF-kB activation 
following muscle contraction and/or an acute bout of exercise (29-31). For instance, 
downhill treadmill running in rats, which has a strong eccentric component, has been 
shown to increase NF-kB DNA binding activity and enhance the expression of genes 
under NF-kB regulation (29, 31).  
  
To more deeply probe the functional significance of NF-kB activity in skeletal muscle 
following EC, we believed it was important to localize the origin of its activity, as its 
effect may be a function of its cellular compartmentalization. For example, NF-kB has 
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traditionally been considered to primarily have anti-myogenic effects in regenerating and 
developing muscle (17, 32). However, Dahlman et al. (33) have recently provided 
compelling evidence that NF-kB activation in muscle-residing fibroblasts can promote 
myoblast proliferation and enhance myogeneis via a nitric oxide synthase (iNOS) 
mechanism in developing mouse muscle. Thus, NF-kB dependent transcription may have 
distinct roles in myogenesis, depending on the origin of its activity. This finding may be 
particularly relevant to our EC model, given that 1) muscle development largely 
recapitulates the molecular events of muscle regeneration following damage (1) and 2) 
recovery from EC involves the activation of satellite cells and a significant regenerative 
response (11, 34). Our initial confocal analysis indicated that the majority of NF-kB 
expression and nuclear localization originated not from the myofibers but from the 
interstitial spaces, specifically from cells adjacent to, or nearby what we suspected could 
be microvessel structures. Therefore, we explored the possibility that NF-kB was 
activated in cells directly associated with (pericytes), or positioned in close proximity to 
(satellite cells), the microvasculature (19). This led to the finding that the majority of NF-
kB activity derived from cells that were positive for pericyte markers. Pericytes are stem 
cell-like constituents of blood microvessels and regulate functions of vascular 
development and remodeling (35). They can be readily distinguished in electron 
micrographs of muscle samples (36); however, the functional roles that they may play in 
muscle, particularly in the periods following eccentric contractions is unknown.  
 
A well-supported potential function for pericyte specific NF-kB activation following EC, 
particularly considering its early activation (3 h), is in the signaling of an inflammatory 
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response. It has been established that EC results in a predictable inflammatory response 
(25) and that this response is most likely necessary for effective regeneration of damaged 
tissue (25, 37, 38). Muscle resident pericytes are strategically positioned along the vessel 
walls to efficiently signal a systemic response. While there are no data on the signaling 
properties of pericyte cells following EC, there is evidence to support a role for 
endothelial cells in the signaling of inflammatory cells via chemokine (c-c motif) ligand 2 
(CCL2, also known as MCP1)(39), which is regulated by NF-kB activity (40). In support 
of this role, we have reported a marked 17.9 fold increase in CCL2 expression via 
microarray. Additional support for a potential inflammatory signaling role is evident in 
our microarray data set, which highlights alterations in several transcripts associated with 
inflammation, for example, the cell adhesion molecules inter-cellular adhesion molecule 
1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM), as well as several interleukins 
and interleukin receptors (IL6, IL18, IL1R1, IL1RL1 and IL1RL2). We have also 
reported increases in expression of CCAAT/enhancer-binding protein delta (CEBPD) via 
qRT-PCR. This finding, a result that we have observed in two previous human EC studies 
(13, 41), lends further support to an NF-kB mediated inflammatory response following 
EC in humans. CEBPD, an inflammatory-related transcription factor, is indirectly 
regulated by NF-kB (42) and moreover, has been shown to regulate the expression of 
CCL2 in vascular smooth muscle (43). 
 
Several recent reports have also provided compelling evidence to support a role for both 
muscle and non-muscle derived pericytes in myogenesis and the restoration of dystrophin 
in mdx mice (21, 44, 45). The myogenic potential of pericytes, along with the activation 
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of a major signaling pathway (NF-kB) associated with muscle regeneration (33), may 
suggest a possible role for pericytes in the regenerative response that follows eccentric 
contractions in humans (10, 11). 
Due in large part to this possibility, we were interested in whether we could detect a 
potential proliferative response by measuring the relative number of pericytes in both EC 
and control muscle samples. We were unable to find such a difference. Though our data 
shed very little light on a potential function for pericytes in the regenerative response 
following EC, we were intrigued to find that approximately 7% of total nuclei per field 
(approximately 8-10 myofibers) stained positive for markers of pericytes. To our 
knowledge, we are the first to report data on the relative pericyte abundance in human 
skeletal muscle cross-sections. However, we must acknowledge that quantification of 
pericyte number in human muscle was a secondary aim, facilitated by our NG2 and ALP 
labeled cross sections. Follow-up work will be important to confirm this finding. 
Consistent with a previous report (12), we were also unable to find a significant 
difference in satellite cell number at 3 h post EC. We interpret this finding, not as 
evidence to support the lack of a regenerative response as a consequence of our EC 
protocol, but rather, as insufficient time to allow for measurable changes to occur. This 
assertion is supported in a recent study by McKay et al. (12) who used a similar knee 
extensor protocol and showed a significant satellite cell response using the Pax7 marker 
at later time points (24, 72 and 120 h), but not at 4 h post.  
  
In summary, our well-powered systems analysis of gene expression changes following an 
eccentric contraction protocol in humans allowed us to make some revealing findings. 
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We have reported the first evidence of NF-kB activation in human muscle following 
eccentric contractions. Furthermore, we were able to localize the majority of that activity 
to muscle resident pericytes and have thus implicated a novel and potentially important 
role for these cells in the response to eccentric contractions in humans. We have also 
generated a significant set of data comprising original and previously reported 
differentially expressed genes from which to develop additional hypotheses. Future work 
will be important in deciphering the functional significance of pericyte-specific NF-kB 
activity in muscle damage, regeneration, and adaptation.  
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CHAPTER IV 
NF-KB ACTIVITY FUNCTIONS IN PRIMARY PERICYTE CELLS IN A CELL- 
AND NON-CELL-AUTONOMOUS MANNER TO AFFECT MYOGENESIS 
 
 
Introduction 
 
 
Skeletal muscle is remarkably proficient at regenerating in response to changing 
functional demands and/or damage. Given its essential roles in locomotion, heat 
production and energy storage, the regenerative capacity of skeletal muscle is essential to 
normal healthy function. The complex mechanisms that regulate the regenerative 
response rely on intricate interactions and signaling patterns between the regenerating 
myofibers, muscle progenitor cells (MPCs), the interstitial environment, and other 
systemic factors.  
 
Skeletal muscle is a heterogeneous mix of multi- and mono-nucleate cell types. In 
addition to the multi-nuleate myofibers, several mono-nucleate cells have been identified 
that normally reside in muscle or infiltrate the tissue following injury. While we still 
know relatively little about the functional interactions between these distinct cell types, it 
is clear that they play an integral role in the acute response and subsequent regenerative 
process following damage. For example, evidence is accumulating to support the 
hypothesis that inflammatory cell signaling plays a central role in muscle regeneration 
following injury (26). Likewise, signaling relationships have been shown to occur 
between muscle residing fibroblasts and myoblasts to enhance myogenesis during muscle 
development and following muscle injury. Mathew et al. (21) have shown that the 
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fibroblast specific transcription factor tcf4 regulates paracrine signaling from fibroblasts 
to myoblasts to enhance muscle fiber formation. Similarly, Dahlman et al. (9) have 
recently reported that stromal fibroblasts regulate fusion of surrounding myoblasts via 
nitric-oxide synthase expression under the control of the transcription factor nuclear 
factor-kappaB (NF-kB). Thus, it is becoming increasingly apparent that paracrine 
signaling from the cellular milieu of skeletal muscle is important in the regulation of 
muscle regeneration. 
 
Recently we have identified NF-kB activation in skeletal muscle resident pericyte cells as 
a potentially important molecular event following eccentric contractions in humans, a 
stimulus known to produce transient muscle injury and subsequent regeneration (18; 
Chapter 3). Therefore, the current study was undertaken to explore the functional 
significance of this finding in the context of muscle regeneration, using an in vitro 
paradigm of myogenesis. I first sought to determine if altered NF-kB activity in cultured 
primary pericytes affected proliferation and/or differentiation of co-cultured skeletal 
muscle mybolasts. Consistent with the emerging anti-myogenic role of NF-kB (2), we 
hypothesized that NF-kB activation in primary pericytes would enhance local myoblast 
proliferation and inhibit differentiation. Furthermore, in light of recent evidence to 
support the myogenic potential of pericyte cells (8, 11, 23), we were also interested in 
determining how altered NF-kB activity affected this potential in cultured primary 
pericytes. We hypothesized that NF-kB activation in cultured primary pericytes would 
decrease their myogenic potential. 
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In the following study we provide additional supporting evidence for the myogenic 
capacity of pericyte cells and a novel role for NF-kB activation in this response. We also 
provide evidence of a potential NF-kB dependent signaling relationship between primary 
pericytes and skeletal muscle myoblasts to regulate proliferation and myotube formation.  
 
Methodology 
 
Cell Culture: Human Primary Pericytes (HPP) were obtained from PromoCell 
(Heidelburg, Germany), where they were isolated from placental tissue and reported as 
positive for the mesenchymal stem cell markers CD146 and CD105, and negative for 
endothelial markers CD31 and CD34. HPPs exhibited a distinct stellate morphology with 
many long cytoplasmic processes, consistent with previously published pericyte 
descriptions. Doubling time in vitro, calculated by linear regression (cell number vs. 
time), was determined to be approximately 40 h under the conditions used in this study. 
Cells were passaged up to 10 times, during which there was no observed trend towards 
senescence at these passage numbers. Cultures were maintained at 37°C in a 5% CO2 
incubator in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% 
Fetal Bovine Serum (GM) and 1% penicillin and streptomycin. Before cultures reached 
90% confluence they were passaged using 0.25% trypsin, 0.1% EDTA. Cells used for all 
experiments were between passages 3-8. C2C12 myoblasts were obtained from the 
American Type Culture Collection (ATCC) and were cultured under the same conditions 
as HPPs. 
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Transient Transfections: Plasmid DNA was transfected into HPPs using a Basic 
Nucleofector Kit for Primary Smooth Muscles (Amaxa, Gaithersburg, MD). We used the 
following expression plasmids: dominant negative (d.n.) IKKβ (K44M), constitutively 
active (c.a.) IKKβ (S177/S188→EE) and an empty vector of the expression plasmid 
(pEF6/HisB; Invitrogen, Carlsbad, CA). The d.n. IKKβ plasmid was developed in the lab 
of Michael Karin (University of California, San Diego, CA) and encodes a kinase-dead 
form of IKKβ. The c.a. IKKβ was developed in the lab of Steve Shoelson (Joselin 
Diabetes Center, Boston, MA) and encodes a constitutively active form of IKKβ. To 
visualize expression of the transfected proteins, the d.n. IKKβ and c.a. IKKβ vectors 
were subcloned into the N-terminus of an EGFP expression vector (pEGFP-n1; Clontech, 
Palo Alto, CA) by the Kandarian lab (Boston University, Boston, MA) to create the d.n. 
IKKβ-EGFP and c.a. IKKβ-EGFP fusion proteins. 10µg of each experimental plasmid 
plus 5µg of reporter plasmid (Clontech, Mountain View, CA) were electorporated into 
5X105 HPPs with a Nucleofector II machine (Amaxa, Gaithersburg, MD) using the P-13 
program. Following electroporation, HPPs were either seeded onto 60-mm plates or slide 
flasks either alone or in co-culture with C2C12 myoblasts or in monoculture.  
 
Luciferase Reporter Assay: HPPs were co-transfected with 5µg of the pNF-kB-MetLuc2-
Reporter plasmid (Clontech, Mountain View, CA) in conjunction with each of the IKKβ 
plasmids as described previously. Twenty-four h post-transfection, medium was collected 
in each condition and luciferase activity was assayed using a Ready-To-Glow Secreted 
Luciferase Reporter Assay (Clontech, Mountain View, CA), according to the 
manufacturer’s instructions. Luminescence measurements were carried out on a 
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FLUOstar Optima plate reader (BMG LABTECH, Offenburg, Germany). A pMetLuc2-
Control Vector (Clontech), driven by constitutively active cytomegalovirus immediate 
early promoter, was used as a positive control for the constitutive expression of metridia 
luciferase. As a positive control for NF-kB activity, we transfected HPPs with 5µg pNF-
kB-MetLuc2-Reporter plasmid and subsequently treated with 10ng TNF-α, a known 
stimulator of NF-kB. 
 
Primary Pericyte/Myoblast Co-Cultures: For all co-culture experiments, HPPs and C2C12 
myoblasts were cultured at ratios between 1:5 and 1:8. In these situations, it was 
estimated that about 50% of transfected HPPs survived and adhered to the slide flask in 
these studies, leaving approximately 7.4x104 cells per flask. C2C12 myoblasts were then 
seeded on to the slide flasks with the adherent HPPs at a density of 3.8x105 cells in 
differentiation medium.  
 
Myoblast and HPP Myogenic Differentiation: To assess myogenesis in the HPP/myoblast 
co-cultures, immunocytochemistry was used to determine myotube formation 96 h 
following the initiation of co-culture. Co-cultures were seeded as described above and 
incubated in differentiation medium (DMEM supplemented with 2% horse serum) for 4 d 
with medium changes every 2 d. Following 4 d of differentiation, cells were fixed for 2 
min in 2% paraformaldehyde at RT.  The cells were then permeabilized for 3 min with 
Karsenti’s Lysis Buffer (0.5% Triton X-100, 80mM PIPES, 1.0 mM MgSO4, 5.0 mM 
EGTA, pH 7.0) after which they were rinsed twice with phosphate buffered saline with 
0.1% Tween-20 (PBST). Cells were then incubated with monoclonal MF20 antibody 
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against myosin heavy chain (Developmental Hybridoma Bank) for 60 min in the dark at 
room temperature. After 3 washes with PBST, the cells will be incubated with 
AlexaFluor 594 anti-mouse (Invitrogen, Carlsbad, CA) for 60 min in the dark.  Cells 
were then washed again 3 times in PBST and nuclei stained with 4,6-diamidino-2-
pheynylindole (DAPI) (Sigma, St. Louis, MO). Co-cultures were visualized and 
photographed using a Nikon model TMS inverted microscope and a SPOT Insight 
imaging color camera (Diagnostic Instruments, Sterling Heights, MI). Images were 
analyzed using Metamorph Imaging software (Molecular Devices, Downington, PA). Ten 
random images from each treatment (c.a. IKKβ, d.n IKKβ or empty vector control) were 
acquired and used for determination of both myotube nuclear number and fiber diameter. 
For myotube diameter measurements, approximately 100 diameters were randomly 
selected for analysis. Three lines running perpendicular to the orientation of the fixed 
myotubes were drawn at evenly spaced intervals across each field of the image using the 
Metamorph software. Diameter measurements were made in micrometers at all points 
where the line crossed a myosin heavy chain (MHC) positive myotube. All experiments 
were replicated 3 times.  
 
Myoblast Proliferation in Co-Cultures: To assess proliferative capacity of myoblasts in 
co-culture with HPPs under the different conditions, cell number was determined 48 h 
and 96 h following the initiation of co-culture. Cells were visualized using DAPI and 
Metamorph Imaging software (Molecular Devices, Downington, PA) was used to count 
the number of cells in 10 randomly acquired images in each condition from 3 replicates.  
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HPP Myogenic Fusion: To determine if HPPs have the capacity to fuse to existing 
myotubes, HPP nuclei were labeled by incubating them in 5-Bromo-2’-deoxy-uridine 
(BrdU) for 48h. Labeled HPPs were then transfected with one of the 3 expression vectors 
(c.a. IKKβ d.n IKKβ or empty vector control) and cultured onto 4 d differentiated C2C12 
myotubes. Co-cultures were incubated in differentiation medium for an additional 3 d. 
HPP nuclei were then detected using a BrdU Labeling and Detection Kit (Roche Applied 
Science, Indianapolis, IN) according to the manufacturer’s instructions. Briefly, co-
cultures were fixed with an ethanol fixative. Following fixation, slides were washed and 
incubated with Anti-BrdU solution for 30 min at 37°C. Slides were then washed again 
and incubated with AlexaFluor 594 anti-mouse secondary antibody (Invitrogen, Carlsbad, 
CA) and 49,6-diamidino-2-phenylindole (DAPI) (Sigma, USA) for 30 min at 37°C. 
Slides were once again washed, air dried and mounted. Stained slides were imaged on a 
Nikon model TE-2000 inverted microscope and a SPOT Insight imaging color camera 
(Diagnostic Instruments, Sterling Heights, MI). Determination of HPPs incorporated into 
myotubes was made based on the presence of a BrdU labeled nucleus within a 
differentiated myotube. Ten random images from each condition (c.a. IKKβ, d.n IKKβ or 
empty vector control) were acquired from 3 separate experiments. To avoid false 
positives due to the pericyte lying underneath or on top of the myotube, visual evidence 
of the myonucleus also had to be present in the phase contrast image.   
 
Western Blots: Co-cultured cells were lysed in a RIPA buffer (20mM Tris pH7.5, 
200mM NaCl, 0.25% Np-40, 1mM PMSF, 1mM Sodium Orthovanadate, 10mM NaF and 
analyzed for total protein concentration using the BCA Assay (Pierce, Rockford, IL). The 
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samples were then be boiled for 5 min. Equal amounts of protein from each sample were 
loaded into 4-15% gradient sodium dodecyl sulfate (SDS) poly-acrylamide gels (Bio-Rad 
Laboratories) and separated by electrophoresis (60-90min@100v). Fractionated proteins 
were transferred to a polyvinylidene diflouride membrane (Millipore, Billerica, MA) at 
100v for 1h.  The membrane was then incubated in the appropriate primary antibody, at 
the appropriate dilution (5% BSA in 1XPBST) with rocking motion overnight at 4 
degrees. Following the incubation in primary antibody, the membrane was incubated in 
the appropriate HRP-labeled secondary antibody (~1:1000) for 1.5 h. Membranes were 
treated with enhanced chemiluminescence (ECL) for two min, wrapped in plastic film, 
and exposed to Kodak film for the appropriate duration. Antibodies were: Rabbit 
polyclonal antibody for GAPDH obtained from Abcam (Cambridge, MA) and a mouse 
monoclonal antibody for MHC obtained from the Developmental Studies Hybridoma 
Bank (Iowa City, IA).  
 
Statistical Analyses: All analyses were carried out in 3 independent experiments. Means 
from each of these independent experiments were analyzed using a one-way ANOVA. 
Where there was a significant difference found, Tukey’s Honest Significant Difference 
test was applied. Significance was set a priori at p<0.05.  
 
Results 
 
Inducible expression of IKKβ constructs: To alter NF-kB activity in HPPs, we transfected 
them with either a constitutively active (c.a.) IKKβ-EGFP, dominant negative (d.n.) 
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IKKβ-EGFP, or an empty vector-EGFP (e.v.) expression plasmid. We estimated, based 
on EGFP fluorescence, that the transfection efficiency after 24 h was 50-60% (Figure 
4.1A). To assess the effectiveness of the IKKβ constructs to alter NF-kB activity in 
HPPs, we used a luciferase reporter assay. Twenty-four h post-transfection, luciferase 
activity was decreased by approximately 50% in the dominant negative IKK (d.n.) 
condition and increased approximately 2.5-fold in response to the constitutively active 
(c.a.) IKK (Figure 4.1B). As a positive control we also treated reporter-transfected cells 
with 10ng/ml tumor nectoris factor-α (TNF-α), a known stimulator of NF-kB activity. 
TNF-α treatment resulted in a 5-fold increase in NF-kB activity. 
                  
Figure 4.1: Altered activation of NF-kB in human primary pericytes (HPPs) following 
transient transfection of IKKβ expression vectors. A) Representative images of HPPs 24 
h following transfection with either an empty vector (e.v.), dominant negative IKKβ-
EGFP (d.n.), or constitutively active IKKβ-EGFP (c.a.) plasmid. Left panel depicts GFP 
expression and the right panel is a phase contrast image. B) NF-kB activity as measured 
by a luciferase reporter 24 h following transfection with IKKβ plasmids. An empty vector 
(e.v.) was used as a control. TNF-α, a known stimulator of NF-kB was used as a positive 
control. Data are means ± SEM. 
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NF-kB activity alters myogenic fusion of HPPs to myotubes: In light of recent data (8, 22) 
that support the hypothesis that in vitro myogenesis of pericyte cells, including placenta-
derived pericytes (23), we asked whether NF-kB activity is important in this response. 
Although HPP cultures varied in their morphology under different medium conditions, 
we were unable to verify that HPPs were myogenic in monoculture. This observation was 
based on the notable absence of myosin heavy chain (MHC) expression and the lack of 
apparent multi-nucleated cells following as many as 15 d in either a differentiation 
medium or conditioned medium from differentiated C2C12 myotubes (data not shown).  
 
We next asked how NF-kB activity affected myogenic activity of HPPs in a 
recapitulation of the in vivo skeletal muscle environment, by culturing them on to 
differentiated myotubes. We labeled the nuclei of transfected HPPs with BrdU to 
distinguish them from other cells and cultured them onto 4 d old differentiated C2C12 
myotubes. Following 3 d of co-culture we found evidence of HPP myogenic activity by 
the presence of BrdU-labeled HPP nuclei inside differentiated myotubes (Figure 4.2A), 
although overall, this was a very infrequent occurrence. In fact, by random image 
sampling (10 random images per condition from 3 separate experiments), we were only 
able to identify 7 instances (less than 1% of all HPP nuclei) of a BrdU-positive nucleus 
within a myotube. However, we did note that of these 7 occurrences, 5 of them were 
found in cells expressing the d.n. IKKβ, suggesting that inhibition of NF-kB promotes 
myogenic fusion of HPPs. Because we found so few myogenic nuclei by random 
sampling, we scanned each slide entirely to identify the total number of myogenic HPPs 
among the three conditions. Among the three replicates, we found a significantly greater 
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number of myogenic HPPs in the d.n IKKβ (23±7.1) expressing cells compared to the 
e.v. (14±4.4) and c.a. IKKβ (10±3.0) expressing cells. There were no differences between 
the e.v. and c.a. IKKβ conditions for total number of BrdU-positive myonuclei. To get an 
indication of how frequently myoblasts fuse with differentiated myotubes under the same 
conditions, we co-cultured BrdU-labeled myoblasts at the same ratio onto 3 d 
differentiated myotubes. We found that there was approximately a 3-fold higher 
proportion of myoblasts fused to myotubes (Figure 4.2B). 
 
         
Figure 4.2: Human primary pericytes (HPPs) can fuse to differentiated myotubes. A) 
Images showing the fusion of an HPP, transfected with a dominant negative IKKβ-EGFP 
(d.n.) expression plasmid to a differentiated myotube. HPPs were labeled with BrdU and 
co-cultured with differentiated myotubes for 3 d. Arrow indicates a BrdU-positive HPP 
nucleus that has fused with a differentiated myotube. B) Images showing the fusion of a 
BrdU-labled myoblast with a differentiated myotube. The frequency of myoblast fusion 
was higher than that of HPPs following 3 d of co-culture. Arrow indicates a BrdU-
positive myoblast nucleus that has fused with a differentiated myotube. Arrowhead 
indicates a BrdU positive myoblast that was determined to lie on top of or beneath a 
myotube because there is no evidence of the nucleus in the phase image. To be 
considered a myonucleus, evidence of the nucleus must have been clear in the phase 
image.    
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Pericyte specific NF-kB activity non-cell-autonomously regulates myoblast 
differentiation: To determine if altered NF-kB activity in pericytes can extrinsically 
regulate myogenesis of local myoblasts, we co-cultured transfected HPPs with cycling 
C2C12 myoblasts that were then subjected to differentiation conditions. We observed a 
marked decrease in myotube development in the coculture c.a. IKKβ expressing HPPs 
compared to cocultures with d.n. IKKβ and e.v. IKKβ expressing HPPs. This was 
confirmed by considerable decreases in MHC expression as measured by both 
immunofluorescence (Figure 4.3A) and Western Blot (Figure 4.3D). Overall, myotubes 
co-cultured with HPPs expressing the c.a. IKKβ expression plasmid had fewer myonuclei 
(skewed distribution of myoneucli per myotube; Figure 4.3B) and a decreased myotube 
diameter (Figure 4.3C) than those that differentiated in the presence of HPPs expressing 
the e.v. or d.n. IKKβ plasmids. Interestingly, we were unable to identify GFP-positive 
HPPs in the d.n. IKKβ condition, suggesting that they had either died over the 96 h 
differentiation period or fused with myoblasts to form differentiated myotubes. However, 
because previous experiments had shown that d.n. IKKβ expressing HPPs were viable 
beyond 96 h (data not shown), it suggested that they had fused to myotubes and the GFP 
signal became to diffuse within myotubes to detect. This would support our finding that 
suppression of NF-kB activity cell-autonomously enhances their myogenic activity. 
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Figure 4.3: Increased NF-kB activity in human primary pericytes (HPPs) inhibits 
myogenic differentiation of co-cultured myoblasts. A) Representative images of 
HPP/myoblast co-cultures for each of the IKKβ conditions and the empty vector control 
following 96 h in co-culture under differentiation conditions. B) Distribution of nuclei for 
each of the IKKβ conditions and the empty vector control following 96 h in co-culture 
with myoblasts under differentiation conditions. Data demonstrate the development of 
myotubes in each condition at 96 h. C) Myotube diameter for each of the IKKβ 
conditions and the empty vector control following 96 h in co-culture under differentiation 
conditions. * signifies a significant difference (P<0.001) from e.v. and d.n. transfected 
HPPs. D) Western blot of lysate from HPP/myoblast co-cultures, under each of the IKKβ 
conditions and the empty vector control following 96 h in co-culture, probed for myosin 
heavy chain (MHC) and GAPDH as a loading control. All data are means ± SEM. 
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Pericyte specific NF-kB activity non-cell-autonomously regulates myoblast proliferation: 
In addition to affecting differentiation, it also became apparent during our image analysis 
that following 96 h of differentiation, our co-cultures with c.a. IKKβ expressing HPPs 
had more cells, suggesting a possible effect on myoblast proliferation. This finding was 
confirmed by counting DAPI positive cells in each condition after 48 and 96 h of co-
culture under differentiation conditions. We found no difference at 48 h, but a marked 
increase in cell number in the c.a. IKKβ condition compared to the d.n. IKKβ and e.v. 
conditions (Figure 4.4A and B). Because the number of GFP-positive HPPs declined over 
the 4 d differentiation period, the increase in cell number was likely due to proliferation 
of the co-cultured myoblasts. 
  
                        
Figure 4.4: Increased NF-kB activity in human primary pericytes (HPPs) promotes 
proliferation of co-cultured myoblasts. A) Images of HPP/myoblast co-cultures for each 
of the IKKβ conditions and the empty vector control, stained for nuclei following 96 h in 
co-culture. B) Cell number following 48 and 96 h of co-culture in each condition under 
differentiation conditions (DM). * signifies a significant difference (P<0.001) from e.v. 
and d.n. conditions at 96 h. All data are means ± SEM.  
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Discussion 
 
In vivo myogenesis requires a coordinated pattern of signaling crosstalk between multiple 
cell types that both reside in and infiltrate skeletal muscle during development and 
following injury (9, 21, 26). Previous work from our laboratory has indicated that 
pericyte-derived NF-kB signaling is an important event in the early response to muscle 
injury in humans (18). We were therefore interested in whether pericyte specific NF-kB 
activity was of consequence to the myogenic response shortly following muscle injury. 
To ascertain the effect of pericyte-specific NF-kB signaling on myogenesis, we used an 
in vitro paradigm of myogenesis (C2C12 myoblasts under differentiation conditions) on to 
which we co-cultured human primary pericyte cells (HPPs). The major findings were 
that: 1) Inhibition of NF-kB activation enhanced the myogenic potential of HPPs in a 
cell-autonomous manner and; 2) Constitutive activation of NF-kB in HPPs non-cell-
autonomously inhibited myogenic differentiation and promoted myoblast proliferation of 
co-cultured myoblasts. 
 
NF-kB affects the myogenic potential of HPPs 
Numerous recent reports have suggested a possible role for perivascular-derived cells as 
non-satellite cell myogenic precursors, capable of spontaneous in vitro myogenesis and in 
vivo rescue of dystrophic rodent muscle (8, 11, 22, 23). In contrast to these studies, we 
were not able to detect spontaneous myogenesis in our HPP cultures over a 15 d period 
under a variety of culture conditions (i.e. conditioned and non-conditioned differentiation 
medium). However, when we cultured HPPs on to developing myotubes, we observed a 
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modest number of HPPs capable of myotube fusion, although that number was 3-fold 
lower than the number of myoblasts that were capable of fusion when co-cultured with 
developing myotubes at the same ratio. The relatively low efficiency of HPP myogenic 
fusion may in part be a function of the species difference between the developing 
myotubes (mouse) and the co-cultured pericytes (human). However, Gentile et al. (13) 
recently reported that human epicardium-derived cells fused to mouse myoblasts with 
high efficiency (12%) when co-cultured at similar ratios to the current study. In contrast, 
they reported that human adipose tissue-derived mesenchymal stromal cells fused less 
efficiently (<1%), suggesting that cell type, rather than species difference may more 
adequately explain myogenic potential. Nevertheless, our data are well supported by 
Kirilova et al. (19) who reported that a preparation of retina-derived perivascular cells 
from mouse likewise did not differentiate spontaneously, yet fused to developing 
myotubes in vitro. A possible explanation for the discrepancy of findings regarding 
spontaneous in vitro differentiation can perhaps be found in the source of the cells. 
Whereas both we an Kirillova et al. (19) used perivascular cells derived from vascular 
rich sources distinct from skeletal muscle (i.e. retina or placenta), others have used 
skeletal muscle-derived pericytes (11, 22). In this regard, skeletal muscle-derived 
pericytes may be more “conditioned” to adopt a myogenic phenotype. Alternatively, 
because these prior studies relied on flow cytometry-based cell sorting to isolate pericytes 
from skeletal muscle tissue, there may have been the possibility for satellite cell 
contamination. 
. 
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Although we found that a relatively small proportion of HPPs were myogenic following 3 
d of co-culture with myotubes, we did observe that inhibition of NF-kB significantly 
increased their myogenic capability. This finding is consistent with the well-supported 
role for NF-kB as a negative regulator of myogenesis (2, 3, 20). Interestingly, we did not 
find that constitutively active NF-kB activity inhibited myogenic activity to a 
significantly greater extent than transfection with an empty vector control plasmid. This 
could be because we were underpowered in that we found so few instances of myogeinc 
HPPs in either condition. Although we did note a lower total number of pericyte nuclei in 
the c.a. condition, there was no statistically significant difference between this condition 
and the empty vector control condition. However, notwithstanding the limited myogenic 
activity of HPPs, our data support the hypothesis that NF-kB inhibition may represent a 
useful strategy to enhance the myogenic inclination of non-satellite cell muscle precursor 
cells, which may be important in optimizing current stem cell strategies for muscle 
degenerative disorders.  
 
NF-kB activation in HPPs affects co-cultured myoblast differentiation and 
proliferation 
In a trophic-rich medium (GM), C2C12 myoblasts have the potential to proliferate 
indefinitely. However, when those growth factors are removed, as in the case of low 
serum culturing conditions, myoblasts will choose one of three developmental fates; A 
large portion of cells will upregulate myogenic regulatory transcription factors (e.g. 
MyoD and myogenin) and differentiate into multinucleated myotubes (25); A subset of 
cells will become quiescent as lineage restricted muscle stem cells (30); and finally, a 
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population of cells will not upregulate survival signals and die by apoptosis (10) (Figure 
4.5). Our data suggest that HPPs with constitutively active NF-kB, either via regulation 
of paracrine signaling or cell contact-mediated interactions, push local myoblasts to re-
enter the cell cycle rather than to differentiate (Figure 4.5). Because HPP number 
declines over the 4 d differentiation period, yet the proliferative effect is most prominent 
at 4 d of co-culture, it is likely that HPPs exert this effect via paracrine signaling rather 
than cell contact-mediated mechanisms. In fact, several secreted cytokines/chemokines 
under NF-kB transcriptional control have been shown to have pro-mitogenic and anti-
differentiative effects on myoblasts. Some of these include monocyte chemoattractant 
protein-1 (MCP-1; CCL2) (27, 29), macrophage inflammatory protein-1α (MIP-1α; 
CCL3) (15, 29), macrophage inflammatory protein-1β (CCL4) (28, 29) and tumor 
necrosis factor-α (TNF-α) (1, 16). Specifically, the CC family chemokines (CCL2, 
CCL3, CCL4) were shown in a recent report to have a direct proliferative and anti-
differentiative effect on local myoblasts, independent of their roles as inflammatory 
chemoattractants (29). Additionally, others have shown in vivo that vessel-associated 
endothelial cells are involved in the recruitment of inflammatory cells via CCL2 
signaling following ischemic injury (24), suggesting that vasculature associated 
constituents, which are located in close proximity to satellite cells (6), provide this dual 
function. We have also shown, that 3 h following muscle damage in humans, that there is 
an increase in pericyte specific NF-kB activity that is accompanied by robust 
transcriptional increases in the expression of CCL2 (17, 18), which is localized to 
satellite cells at 6 h post injury (17). Thus, the CC chemokines, specifically CCL2, 
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represent a group of strong candidates for NF-kB dependent signals that may be 
responsible for our observed effects.  
         
 
Figure 4.5: Model of cell- and non-cell-autonomous effects of pericyte-derived NF-kB 
activation on local myoblasts under differentiation conditions: In low trophic factor 
medium (DM), myoblasts will choose one of three developmental fates; differentiation to 
multinucleated myotubes, quiescence or apoptosis. Activation of NF-kB in co-coltured 
pericytes promotes myoblast proliferation in lieu of quiescence and inhibits myoblast 
differentiation, likely via paracrine signaling of an unknown secreted factor. It is 
currently unknown whether this event affects cell death of myoblasts in DM. 
Additionally, NF-kB de-activation enhances myogenic differentiation of pericyte cells.  
 
The model in Figure 4.5 depicts how pericyte-derived NF-kB activity influences both 
intrinsic and extrinsic myogenic activity based on our data. While it is clear that non-
satellite cell populations are capable of giving rise to myogenic-competent cells, and our 
data lends support to this notion, it is becoming widely-accepted that satellite cells are the 
primary source of muscle stem cells used for muscle growth and repair (5, 12).  It is also 
evident that cell-cell contacts and extracellular signaling from the local niche play a role 
in myogenic activity of satellite cells (4, 21), yet this represents one of the most 
underexplored areas of satellite cell research (5). The spatial proximity of satellite cells to 
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the microvasculature has, for some time, been thought to foster interactions and facilitate 
systemic and local signaling to influence satellite cell activity (6). Our findings support 
this cross-talk relationship and furthermore, implicate NF-kB signaling as a key mediator. 
This finding may have particular relevance for age-related skeletal muscle loss, which is 
characterized by a loss of regenerative capacity (14). Age-associated reductions in 
regenerative capacity seems to be fundamentally dependent on the local muscle 
environment, as satellite cells from old muscle regain their myogenic potential when 
transplanted into young muscle (7). Our data support a role for vascular-associated 
pericyte cells as important constituents of that regulatory environment. 
 
Conclusion 
In summary, We have provided additional supporting evidence for the myogenic 
capability of pericyte cells, although under our conditions, their contribution to in vitro 
myogenesis appears minor. We also demonstrate that, in addition to their potential as 
myogenic precursor cells, which has been the focus of much recent research, pericytes 
can function in a non-cell-autonomous manner to regulate myogenic activity of local 
muscle progenitors. Furthermore, we have determined that NF-kB dependent signaling 
plays an integral role in both the autonomous and non-cell-autonomous myogenic 
contribution of pericytes. 
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CHAPTER V 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
Conclusions 
 
 
Driven primarily by the prospect of using stem cell therapy for the treatment of skeletal 
muscle loss associated with disease (i.e. Duchenne muscular dystrophy; DMD) and 
aging, there has been great interest in understanding the mechanisms of skeletal muscle 
myogenesis. Consequently, there has been a significant increase in the number of studies 
addressing these mechanisms in the recent years. However, a major limitation to our 
ability to translate this information to meaningful treatment outcomes is a paucity of data 
in relevant models of myogenesis in humans. While genetic animal models will continue 
to be valuable in unfolding the detailed molecular underpinnings of myogenesis, new 
data appear to suggest that there are fundamental differences between the human and 
rodent myogenic response (2). For example, virtually all of the work that has been done 
on satellite cell quiescence, activation and self-renewal has been performed with mouse 
satellite cells (6, 16), leaving doubt as to whether the same mechanisms are recapitulated 
in humans. Therefore, the overall objective of this dissertation was to characterize and 
identify early novel changes in molecular pathways and signaling in human muscle 
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following eccentric contraction-induced muscle damage, a stimulus known to result in a 
regenerative myogenic response.  
 
To address this objective I used a translational “bedside to bench top approach.” That is, 
cellular and molecular observations were made in a relevant model of muscle 
regeneration in humans that were then used to ascertain potential mechanisms of action 
using in vitro methodology. Results from the human study (Chapter 3) provided novel 
evidence of NF-kB activation in human muscle following muscle eccentric contractions 
that was localized primarily to muscle residing pericytes. Subsequent in vitro analyses 
(Chapter 4), using human primary pericytes (HPPs) with genetically induced over-
activation of NF-kB showed that NF-kB functions intrinsically to inhibit myogenesis of 
HPPs and extrinsically to promote local myoblast proliferation and inhibit myoblast 
myogenic differentiation. Taken together, the fact that NF-kB activation (3 h) precedes 
the early proliferative response of satellite cells (Figure 2.1), suggests that pericyte-
specific NF-kB activation may act to promote satellite cell proliferation and inhibit 
myogenic differentiation in the early hours following muscle injury. Proliferation of 
satellite cells following injury has been shown to be essential for muscle regeneration 
(Figure 2.2), yet the signals that regulate this critical event are largely unknown. This 
early pro-proliferative/anti-myogenic response is critical to ensure that the normally 
quiescent satellite cell pool is sufficient for both muscle repair and niche maintenance. As 
detailed in the discussion of Chapter 4, it is likely that this NF-kB dependent regulatory 
mechanism is mediated by paracrine signaling of chemokines, which may additionally 
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play a dual role in recruiting inflammatory molecules (15). A schematic of this proposed 
model, based on data from this dissertation is provided in Figure 5.  
 
 
Future Directions 
 
I have speculated that the non-cell-autonomous effects of pericyte-derived NF-kB activity 
on myoblast myogenesis is mediated by paracrine signaling (Chapter 4). Alternatively, 
cell-cell interactions could have produced the observed effects, although this is unlikely 
due to low pericyte/myoblast ratios that exist at later time points. Nevertheless, it will be 
important for future work to determine the exact mechanism of action via similar trans-
well experiments conducted by Mathew et al. (8).  If in fact paracrine signaling underlies 
the non-cell-autonomous effects of NF-kB activation in pericytes, the identification of the 
secreted factors under NF-kB control would be important in further defining the 
environmental signals that are critical for effective muscle regeneration. Dahlman et al. 
(4) have recently provided an exemplary pattern for the elucidation of paracrine signaling 
in muscle resident cells. They observed that NF-kB activation in muscle resident 
fibroblasts was critical for proper muscle development in mouse neonates. Using mouse 
genetic models they were able to show that NF-kB dependent expression of nitric oxide 
synthase (iNOS) was responsible for the observed non-cell-autonomous effects of 
fibroblasts on local satellite cells. Certainly, a similar pattern of experiments could be 
conducted using a candidate gene approach; for example, CCL2 (as discussed earlier) or 
iNOS. Alternatively, genetic screening via microarray could be used to identify highly 
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expressed transcripts for secreted factors in pericytes with altered NF-kB activity. This 
type of analysis could then be followed up using mouse genetic and in vitro models to 
determine their effect on local myoblast proliferation and differentiation. 
 
This dissertation has also provided evidence confirming the myogenic potential of 
pericytes and the involvement of NF-kB in that developmental decision (Chapter 4). 
Several groups have reported that using muscle and non-muscle derived pericytes is a 
viable stem cell treatment strategy in models of DMD (3, 5, 10, 11). In each case, 
pericytes have been used successfully to restore dystrophin expression in the dystrophin-
null mdx mouse, yet the extent of rescue has been limited to the local area of intra-
muscular pericyte injections. However, in one case (10), pericytes were mildly effective 
at restoring dystrophin expression when delivered systemically through the vasculature. 
In this regard, pericytes hold promise as potentially effective stem cells for the treatment 
of DMD, as they have been shown to effectively move out of the vasculature and into 
skeletal muscle (12). Data from this dissertation have shown that inhibition of the NF-kB 
signaling pathway (by only approximately 50%) significantly increases myogenic 
potential of pericyte cells. Therefore, it is likely that inhibition of NF-kB may be a viable 
strategy to increase the myogenic efficiency of pericyte cells in the treatment of DMD. 
Additionally, it is unknown whether pericytes contribute in vivo to muscle repair 
following injury. Although it is generally believed that satellite cells are the principle, if 
not sole, progenitors responsible for the repair of injured muscle (6), no study has yet 
looked at the contribution of pericytes to muscle repair. Unlike bone marrow-derived 
hematopoietic cells, which have also been studied extensively as a potential myogenic-
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competent stem cell (7, 9, 12), pericytes are natively found in skeletal muscle and, in fact, 
constitute approximately 7% of all nuclei found in human skeletal muscle cross sections 
(Chapter 3). Their proximity to skeletal muscle therefore makes them well suited to the 
role of skeletal muscle repair. 
 
It is well established that muscle damage is accompanied by a predictable and well-
characterized infiltration of inflammatory cells (14). Furthermore, the infiltration of 
inflammatory cells has been shown to be essential for normal, effective regeneration (1, 
13). In the Chapter 4 discussion, I also speculate that pericytes contribute to the 
recruitment of inflammatory cells following muscle damage. Data from this dissertation 
show clearly that pericytes respond to muscle damage by altering activation of a major 
signaling pathway associated with inflammation (NF-kB) and the recruitment of 
monocytes. It is therefore possible that pericytes play a dual role (as described 
schematically in Figure 5) in the secretion of NF-kB dependent paracrine factors to affect 
satellite cell activation and proliferation, as well as the recruitment of inflammatory cells 
from the circulation. Given their proximity to both satellite cells and the vasculature, this 
dual role is certainly worth further exploration. In conclusion, the data presented in this 
dissertation will pave the way for studies to further explore the interactive role of 
pericytes and skeletal muscle in muscle regeneration. 
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Figure 5.1: Proposed model of molecular and cellular signaling following muscle injury 
in humans, based on data from this dissertation and published research. Shortly following 
muscle injury, NF-kB is activated in muscle residing pericytes. Activation of NF-kB 
results in secretion of cytokines/chemokines, which promote the proliferation of satellite 
cells. Additionally, these cytokines/chemokines may play a role in recruiting 
inflammatory cells. The expanded satellite cell pool then migrates to the site of damage 
and fuses to repair the fiber. Infiltrating inflammatory cells provide further signaling 
input to promote proliferation and differentiation of satellite cells. Additionally, pericytes 
may contribute to myofiber repair by fusing to the damaged fiber during later phases of 
regeneration.   
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APPENDIX 
 
KNOCKDOWN OF METALLOTHIONEIN 1 AND 2 DOES NOT AFFECT 
ATROPHY OR OXIDANT ACTIVITY IN A NOVEL IN VITRO MODEL 
 
 
The work for this study was done just prior to the previously discussed dissertation 
studies and serves as a proof of concept for how in vitro models can be used effectively 
to elucidate the mechanistic relationships of observations made in humans. In addition to 
providing novel data on the role of metallothioneins during muscle atrophy, this study 
also set the stage for my dissertation studies by providing invaluable experience using in 
vitro models and inducible gene expression paradigms. It was published in the Journal of 
Applied Physiology in November 2010.   
 
Hyldahl RD, O’Fallon KS, Schwartz LM, Clarkson PM. Knockdown of 
metallothionein 1 and 2 does not affect atrophy or oxidant activity in a novel in vitro 
model. J Appl Physiol, Nov 2010; 109: 1515-1523. 
 
 
 
Introduction 
 
 
Skeletal muscle atrophy occurs from a myriad of distinct stimuli. Conditions generally 
resulting in atrophy include immobility, disuse, denervation, or as the consequences of 
certain chronic disorders such as sarcopenia, cancer, AIDS and diabetes (28-32).  Muscle 
atrophy is commonly characterized by a loss of balance between protein synthesis and 
degradation that ultimately results in a net loss of contractile proteins (17, 33). Atrophy 
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results in decreased muscle fiber size, force production and fatigue resistance, which in 
turn can lead to weakness, instability and a decreased quality of life.  
 
Muscle atrophy can be mediated by a number of distinct signal transduction pathways. As 
examples, disease-related atrophy is brought about by elevated levels of circulating 
cytokines and/or glucocorticoids (34-36), while disuse atrophy appears to be triggered by 
intracellular signaling events as a result of decreased muscular tension (13). Muscles that 
no longer bear weight or are immobilized for extended periods of time initiate pathways 
leading to protein loss, and some of these pathways have been well characterized (4, 37).  
However, potential upstream molecules regulating these processes are still poorly 
defined.  
 
It has been extensively documented that expression of metallothioneins (MT) are 
significantly upregulated in muscle cells following an atrophy stimulus in both humans 
and animal models (32, 38-40).  MTs are ubiquitously expressed proteins with a diversity 
of reported intracellular functions (41). In rodents, there are 4 known isoforms of MT (1-
4), two of which (MT1 and 2) are expressed in skeletal muscle. In humans, at least 17 
isoforms have been identified. Different isoforms of MT are distributed in a wide variety 
of tissue, and for the most part, appear to have redundant functions although some 
specialization has been noted (42). While it has been difficult to define a consensus 
biological function for MTs, it is clear that they play important roles in both binding of 
heavy metals and as endogenous antioxidants (43). More recently, their role as 
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antioxidants and their ability to protect against oxidative damage in various tissues has 
been elucidated (44).  
 
As part of our ongoing studies to define the molecular mechanisms that mediate skeletal 
muscle atrophy in humans, we have performed microarray analysis with mRNA isolated 
from muscle biopsies 48 hours after knee joint immobilization, unilateral lower limb 
suspension and spinal cord injury (32, 38) (K Sewright-Reich, unpublished observations). 
This unique set of data, collected at the same time point relative to the experimental 
manipulation or injury for three distinct conditions, has permitted a detailed comparative 
analysis to ascertain a possible common program for gene expression following disuse. 
One of the few gene clusters to be commonly increased following all 3 forms of disuse 
was the MTs.  These observations are consistent with data from animal models, where a 
significant increase in MT mRNA has been measured following a diverse range of 
atrophy-inducing manipulations (31, 39, 45). Despite the preponderance of gene 
expression data indicating increased expression levels of MTs following an atrophy 
stimulus, the potential role(s) for MT in the muscle atrophy program have not been 
identified. Given their ability to scavenge free radicals and protect against oxidative 
injury (46), it has been suggested that increases in MT expression may be an initial 
response to offset increases in oxidative stress associated with a muscle atrophy stimulus.  
 
In the current study, we have employed the use of an in vitro model of muscle atrophy to 
test the hypothesis that transient MT gene knockdown would result in greater oxidative 
stress and an enhanced response to an atrophy stimulus. Given the inconsistencies of 
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current modes of atrophy induction in C2C12 myotubes (47, 48) and their requirement for 
exogenous factors not normally associated with disuse atrophy, we have also sought to 
develop and characterize a novel in vitro model of muscle atrophy to test our hypothesis. 
Herein we describe a simple and reliable method for the induction of atrophy in culture 
myotubes and subsequently apply this model to more clearly delineate the role of MTs 
during muscle atrophy. 
 
Methodology 
 
Cell Culture to Induce Myotube Atrophy: C2C12 myoblasts were obtained from the 
American Type Culture Collection (ATCC) and expanded and frozen down.  Only early 
passage cells were used in these studies.  For experiments, cells were incubated in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% Fetal Bovine 
Serum (Atlanta Biologicals Norcross, GA), to create a growth factor rich growth medium 
(GM) at 37oC in 10% CO2. At 80-90% confluence, cells were transferred to 
differentiation medium (DM) (DMEM plus 2% horse serum (Hyclone, Logan, UT)) to 
induce myotube formation. Following 4 days in DM, fused myotubes were re-introduced 
into the high serum GM for 48 hours to produce a hypertrophic response (Figure A.1). 
Experimental cells were then switched back to DM for a maximum of 72 hours to 
produce the desired atrophic response (serum reduction (SR)). Control cells remained in 
GM (See Figure A.1). Data were collected at baseline, 6, 12, 24, 48 and 72 hours under 
the growth factor reduced and control conditions.  
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siRNA: All siRNA duplexes were obtained from IDT (Coralville, IA) and used at a final 
concentration of 10nM for knockdown experiments. The sequences for the MT1 and 
MT2 siRNA duplexes were as follows: MT1, 5’-
AGCGUCUUCCUAUACAGUUCCACCC-3’ and MT2, 
5’GUAAAUAGACCAUGUAGAAGCCUAG-3’. A standard non-silencing, scrambled 
control siRNA duplex was obtained from IDT (Coralville, IA). 
 
Transfections: Following 4 days of differentiation (the onset of GM re-introduction), 
myotubes were transfected in either 24-well plates, 6-well plates or slide flasks with 
10nM MT1, MT2 or scrambled control (non-silencing) siRNA nucleotides using 
Lipofectamine RNAi max (Invitrogen, Carlsbad, CA). This time point was chosen so that 
MT1 and MT2 expression would be reduced at the onset of DM re-introduction (0h). 
Both Lipofectamine and the appropriate siRNA sequence(s) were first diluted 
individually in Opti-MEM I Reduced Serum medium (Invitrogen, Carlsbad, CA). The 
diluted Lipofectamine and siRNA sequence(s) were then mixed and allowed to complex 
for 20 minutes at room temperature. Lipid/siRNA complexes were added to each well at 
a concentration of 10nM in an appropriate volume for each plate size and incubated for 
24 hours. After 24 hours, transfection medium was removed and replaced with GM. A 
scrambled, non-silencing sequence was transfected into parallel wells for all experiments. 
To determine transfection efficiency and siRNA stability, parallel cultures were also 
transfected with TYE-563 labeled double stranded control sequences (IDT, Coralville, 
IA) under the same conditions. Myotubes were then visualized and photographed using a 
Nikon model TMS inverted fluorescence microscope and a SPOT Insight imaging color 
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camera (Diagnostic Instruments, Sterling Heights, MI). Efficiency of knockdown was 
also determined on the RNA level with quantitative real-time PCR (qRT-PCR) and on the 
protein expression level using Western blot analysis.  
 
Immunocytochemistry: To assess changes in myotube morphology, myoblasts were 
grown in chamber slide flasks and treated as above. At each time point, myotubes were 
fixed for 2 minutes in 2% paraformaldehyde at room temperature.  The myotubes were 
then permeabilized for 3 minutes with Karsenti’s Lysis Buffer (0.5% Triton X-100, 
80mM PIPES, 1.0 mM MgSO4, 5.0 mM EGTA, pH 7.0), after which they were rinsed 
twice with PBST (PBS, 0.1% Tween-20). Myotubes were then incubated with the mouse 
monoclonal MF20 antibody against myosin heavy chain (Developmental Hybridoma 
Bank, Iowa City, IA) for 60 minutes in the dark at room temperature. After 3 washes with 
PBST, the myotubes were incubated with AlexaFluor 488 anti-mouse (Invitrogen, 
Carlsbad, CA) for 60 minutes in the dark.  Myoubes were washed again 3 times in PBST 
and nuclei stained with 4,6-diamidino-2-pheynylindole (DAPI) (Sigma, St. Louis, MO). 
Samples were visualized and measured as described below. 
 
Myotube Morphology Analysis: Myotubes were visualized and photographed with a 20X 
objective on a Nikon model TE-2000 inverted microscope and a SPOT Insight imaging 
color camera (Diagnostic Instruments, Sterling Heights, MI). The diameters of the 
myotubes were quantified using Metamorph Imaging software (Molecular Devices, 
Downington, PA) at 24, 48 and 72 hour time points under all experimental and control 
conditions. Approximately 100 diameters were randomly selected from 12 representative 
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microscope fields in each condition from 3 independent experiments. Three lines running 
perpendicular to the orientation of the fixed myotubes were drawn at evenly spaced 
intervals across each field using the Metamorph software. Diameter measurements were 
made in micrometers at all points where the line crossed a myosin heavy chain (MyHC) 
positive myotube.  
 
Total RNA, DNA, and qRT-PCR: Plates were scraped and the myotubes separated from 
the residual mononucleated myoblasts by filtering through a 50 µm sieve. Verification of 
the separation was made via phase contrast microscopy.  Total RNA was extracted from 
myotubes at 6, 12, 24 and 48 hours following SR using TriZol reagent (Invitrogen 
Carlsbad, CA) according the manufacturer’s instructions. RNA concentration was 
determined by optical density on the Nanodrop ND-100 spectrophotometer (Nanodrop 
Products, Willmington, DE). Total RNA was reverse transcribed using a cloned murine 
leukemia virus reverse transcriptase (Fermentas, Glen Burnie, MD) according to the 
manufacturer’s instructions. The relative levels of MT1, MT2, Atrogin1 and MuRF1 
mRNAs were determined by quantitative real-time PCR (qRT-PCR).  ABgene Absolute 
qPCR SYBR Green Master Mix (ABgene, Surrey, UK) with ROX dye was used for all 
PCR protocols.  qRT-PCR reactions were performed in 96-well plates with all cDNA 
samples from each time point for both experimental and control myotubes run in 
triplicate for each gene of interest. The average cycle threshold (Ct) value for triplicate 
samples was used for data analysis. Samples were run for 40 cycles of amplification on a 
MX3000p Real-Time PCR System (Stratagene, La Jolla, CA). At the end of each 
reaction, a melting curve analysis was run to ensure target specificity. Differences in gene 
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expression were determined by the delta Ct relative quantification method. Values were 
normalized to the levels of glyceraldehyde 3-phosphate dehydrogenase (GAPDH), an 
internal reference gene whose expression did not change in response to the treatment 
(data not shown).  Forward and reverse primers (IDT, Coralville, IA) for all genes of 
interest (see Table A.1 for sequences) were designed using NCBI gene sequences with 
the Primer Express program v 2.0 (Applied Biosystems, CA). All primers were tested for 
efficiency via a standard curve and demonstrated efficiencies between 95 and 104%. 
 
Table A.1: Primer sequences 
 
 
Western Blotting and Antibodies: C2C12 myotubes were isolated as above, and incubated 
in lysis buffer (20mM Tris pH7.5, 200mM NaCl, 0.25% Np-40, 1mM PMSF, 1mM 
sodium orthovanadate, 10mM NaF) on ice for 1h. The cell lysate was then centrifuged at 
10,000xg for 10 minutes and the supernatant was removed. Protease inhibitor cocktail 
(Roche Applied Science, Indianapolis, IN) was then added to all samples. Samples were 
analyzed for total protein concentration using the BCA Assay (Pierce, Rockford, IL). The 
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samples were boiled for 5 minutes and equal amounts of protein were loaded into 4-15% 
gradient sodium dodecyl sulfate (SDS) poly-acrylamide gels (Bio-Rad Laboratories) and 
separated by electrophoresis (60-90min@100v). Fractionated proteins were transferred to 
a polyvinylidene diflouride membrane (Millipore, Billerica, MA), which was then 
incubated with the primary antibody in 5% BSA in 1XPBST with rocking motion 
overnight at 4 degrees C.  After washing in PBS supplemented with 0.5% tween-20, the 
membrane was incubated with an HRP-labeled secondary antibody. Membranes were 
then treated with enhanced chemiluminescence (ECL) for two minutes, wrapped in 
plastic film, and exposed to Kodak film. Bands from each blot were quantified via 
densitometry using ImageJ software (NIH). The antibodies used include: rabbit 
polyclonal anti-GAPDH (1:5000; Abcam, Cambridge, MA); mouse anti-myosin heavy 
chain monoclonal antibody MF20 (1:100, Developmental Hybridoma Bank, Iowa City, 
IA); rabbit polyclonal anti-phospho-AKT (ser473) (1:500, Cell Signaling Technology, 
Beverley, MA); rabbit polyclonal anti-metallothionein antidody (which recognizes all 
MT isoforms) (1:100, Santa Cruz Biotechnology, Santa Cruz, CA); and  anti-mouse and  
anti-rabbit HRP-conjugated secondary antibodies (1:1000, Bio-Rad Laboratories, 
Hercules, CA). 
 
Assessment of Intracellular Oxidant Activity: A 5-(and-6)-carboxy-
2’7’dichlorodihydrofluorescein, diacetate, acetyl ester (CM-H2DCFDA) (Invitrogen, 
Carlsbad, CA) assay was used to measure intracellular oxidant activity and provided a 
non-specific measure of oxidative stress. The chemically reduced parent compound (CM-
H2DCFDA) is non-fluorescent until the acetate groups are removed by intracellular 
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esterases. Oxidation by radical species occurs within the cell and forms fluorescent 
dichlorofluorescein (DCF). Fresh stock solutions of CM-H2DCFDA were reconstituted in 
cell culture grade DMSO (ATCC) and diluted in 1XPBS (≤ 0.01% vol/vol PBS) 
immediately prior to each experiment. Extracellular hydrolysis of CM-H2DCFDA was 
minimized using PBS as a loading buffer. After dye loading, a ~15 minute recovery 
period was given to allow cellular esterases to hydrolyze the acetate groups on the dye 
that prevent oxidation. This process renders the dye responsive to oxidation by free 
radicals. All experiments were conducted in darkness to reduce inadvertent photo 
bleaching. Prior to experimental manipulations, myotubes cultured in sterile 96 well 
plates were washed once with PBS and incubated in loading buffer (PBS supplemented 
with 10μM CM-H2DCFDA) for ~30 minutes at 37ºC. Cells were then washed twice with 
PBS and incubated for ~15 minutes (recovery period) prior to returning myotubes to their 
corresponding experimental culture medium (serum reduced or control). DCF 
fluorescence was measured at 37ºC on a fluorescence multiwell microplate reader 
(FLUOstar Optima, BMG LABTECH) at excitation and emission wavelengths of 485nm 
and 538nm, respectively. Baseline DCF fluorescence was measured immediately prior to 
SR and at 1, 2, 4, 6, 12, 24, and 48 hours post-SR. Background auto-fluorescence of DCF 
(measured from both DM and GM containing myotube-free 8 well lanes of each 96 well 
dish) was subtracted from negative controls and the corresponding experimental or 
control myotubes. Net intracellular oxidant activity in the serum-reduced conditions was 
expressed as the percentage of DCF fluorescence in the control condition (high serum). 
The rate of change in intracellular oxidant production was calculated as the average slope 
of the normalized values between time points. 
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Statistical Analysis: Data are presented as means ± SE. All qRT-PCR, morphology, 
Western blot and DCF data were analyzed using a two-way analysis of variance 
(ANOVA) with factors for treatment and time. Where there was a significant effect, 
Tukey’s Honest Significant Difference test was applied. All statistical analyses were 
computed using a SAS statistical software package. Significance was set a priori at 
p<0.05. 
 
Results 
 
Development of an in vitro model for skeletal muscle hypertrophy and atrophy. To 
examine the role(s) of metallothioneins in muscle atrophy, we needed to develop an 
appropriate in vitro model.  After several experimental paradigms, we selected the one 
outlined in Figure A.1.  Briefly, we differentiated C2C12 myoblasts into myotubes by 
changing the cells from a growth factor rich growth medium (GM) to a differentiation 
medium (DM) that was deficient in these factors.  After 4 days in DM, myotubes were 
returned to GM for two more days.  Control cultures remained in GM for the subsequent 
two days while test cultures (referred to as “SR” for serum reduced) were returned to DM 
for the same period of time.  
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Figure A.1: Schematic drawing depicting the serum reduction (SR) paradigm used to 
produce myotube atrophy and for testing the effect of metallothionein knockdown. C2C12 
myoblasts were differentiated for 4 days in low serum differentiation medium (DM) 
followed by a 2-day period of myotube growth in high serum growth medium (GM). 
Control cells remained in GM following the 2-day growth period and SR myotubes were 
put again in low serum medium (SR) to induce the desired atrophic response. The 
specific analyses at each time point are detailed in the methods. 
 
 
We then tested the hypothesis that SR results in myotube atrophy as measured by 
myotube diameter and protein loss. Myotube diameter was found to be significantly 
decreased in SR cultures relative to the GM control cells at 24, 48 and 72 hours (p<0.01) 
(Figure A.2A and B). Additionally, myotube diameter was significantly different at all 
time points under the SR condition compared to baseline (0h) levels (p<0.05). Myotube 
diameter was expressed in micrometers, rather than as a percentage of control to 
demonstrate that significant decreases in size were being driven by SR rather than an 
increase in size of the control myotubes. Further confirmation of morphological changes 
following SR was assessed by changes in the protein expression of the sarcomeric protein 
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myosin heavy chain (MHC). We found that 24, 48 and 72 hours of SR was effective at 
reducing MHC levels relative to control cells (p<0.01) and over time compared to the 
baseline level (p<0.01) (Figure A.2C and D).  GAPDH was used as a loading control for 
the Western blots. 
 
 
Figure A.2: Serum Reduction (SR) reduces myotube diameter and myosin heavy chain 
(MHC) protein content. A) Representative images from control and SR myotubes at 24, 
48 and 72 hours stained with an antibody against MHC. The unlabeled dots are 
myonuclei. Scale bar equals 100µm. B) Myotube diameter of control and SR myotubes at 
24, 48 and 72 hours; data are expressed as mean diameter in micrometers plus and minus 
the SEM.  Data are from 4 independent experiments. * = significant differences from 
control myotubes (p<0.01), ‡ indicates significant differences from myotubes at baseline 
(0h) (p<0.05). C) Representative Western blots of MHC and GAPDH (loading control) 
expression  from control and SR myotubes at 24, 48 and 72 hours. D) MHC protein in SR 
treated myotubes from 4 independent experiments expressed as a percentage of control. * 
= significant differences from control myotubes (p<0.01), ‡ indicates significant 
differences from myotubes at baseline (0h) (p<0.01). 
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SR-mediated changes in protein synthesis/degradation pathway components. To further 
characterize the SR model of atrophy, we used Western blot analysis to monitor the 
expression of several key regulatory proteins. Phosphorylation of the serine/threonine 
kinase AKT is associated with cell growth (4).  The levels of AKT phosphorylation at 
ser473 significantly declined over time following transfer to SR (Figure A.3A and B).  In 
contrast, transfer of myotubes into GM resulted in AKT phosphorylation at 12h and 72h. 
SR treatment also led to increased expression of the atrophy associated ubiquitin E3 
ligases atrogin1 and MuRF1 at 48 hours by 1.8 and 2.1 fold, respectively, when 
normalized to control cells (p<0.05) (Figure A.3C). 
 
                
   
Figure A.3: Decreased activation of AKT and increased expression of the ubiquitin E3 
ligases atrogin1 and MuRF1 in myotubes in response to SR treatment. A) Representative 
immunoblot of phosophorylated AKT (ser473), total AKT and GAPDH over time in 
control and SR myotubes. B) Densitometry measurements of the phosphorylation state of 
AKT in SR treated myotubes from 3 independent experiments, expressed as p-
AKT/AKT. * = significant differences from control myotubes (p<0.01), ‡ indicates 
difference from myotubes at baseline. C) qRT-PCR analysis of atrogin1 and MuRF1 
mRNA expression over time in SR treated myotubes from 4 independent experiments. 
Data are presented as fold change relative to control myotubes. Dashed line indicates 
control myotube level, or no change. * = significant difference from control myotubes 
(p<0.05). 
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Metallothionein expression in SR and siRNA transfected myotubes. To determine if MT is 
induced in our SR model similarly to other atrophy models, we measured endogenous 
MT1 and MT2 expression at various time points following SR. Expression of MT1 and 
MT2 mRNA increased by 2.3 and 2.6 fold, respectively, at 6 hours post-SR compared to 
control myotubes (Figure A.4A). There were no other significant differences in 
expression of either gene at any other measured time point. Both genes also tended to 
follow a very similar pattern of expression.   
 
We next designed siRNA sequences that would selectively target MT1 and MT2 
transcripts.  Following co-transfection of myotubes with these siRNAs 48 hours prior to 
SR, we observed that there were 78% and 69% reductions in the basal levels of MT1 and 
MT2 mRNA, respectively at the 0 hour time point (beginning of the SR stimulus). At 24h 
post-SR (Figure A.4B), there were 82% and 69% for MT1 and MT2, respectively. 
Western blot analysis was used to verify that decreases in MT mRNA resulted in 
decreases in protein expression. At 48 hours post-MT1 and MT2 siRNA co-transfection 
(0h), there was a notable reduction in MT protein (Figure A.4C). 
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Figure A.4: MT expression in control and siRNA transfected myotubes in control and 
SR treated cells. A) Endogenous MT1 and MT2 expression in SR treated myotubes 
compared to control myotubes from 3 independent experiments. * =  significant 
differences from control myotubes (p<0.01) B) Expression of MT1 and MT2 at baseline 
(0h) and 24 hours post-SR in myotubes that were transfected 48 hours prior with siRNA 
duplexes targeted at MT1 and MT2. C) Immunoblot using an antibody that recognizes all 
MT isoforms, 48 hours following transfection (0h) with either siRNA targeted at MT1 
and MT2 or a scrambled control siRNA sequence. 
 
 
Oxidant activity in SR and siRNA transfected myotubes. One of the more well 
characterized roles for MTs in cells is to quench free radical levels (44). To measure 
intracellular oxidant activity in myotubes, we took advantage of the  dichlorofluorescin 
(DCF) assay.  Myotubes were pre-loaded with DCF and then fluorescence intensity was 
measured at 0, 6, 12, 24 and 48 hours post-SR. SR resulted in a significant increase in 
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oxidant activity over time compared to control myotubes (p<0.01) (Figure A.5A and B), 
with the greatest changes occurring at the early time points between 6 and 12h post-SR 
(Figure A.5B). Knock-down of MT expression with siRNAs did not significantly reduce 
SR-induced increases in oxidant activity (Figure A.5).  
 
                     
Figure A.5: Intracellular oxidant activity increases following SR, but is not affected by 
MT1 and MT2 knockdown. A) Oxidant activity normalized to control myotubes over 
time from 3 independent experiments. B) The rate of change in oxidative activity 
development following SR for each time period over the 2-day experiment, calculated by 
the slope of the line between the two time points.  
 
 
Myotube diameter in siRNA transfected myotubes. To determine the effect of MT1 and 
MT2 knockdown on the development of muscle atrophy, we co-transfected myotubes 
with an siRNA sequence specific for MT1 and MT2 or a control, non-silencing siRNA 48 
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hours prior to SR. Myotube size was calculated by measuring myotube diameters in each 
condition. Representative images of siRNA, control siRNA and non-treated (SR) 
myotubes following 48 hours of SR are shown in Figure A.6A. Knockdown of MT1 and 
MT2 did not augment myotube atrophy as we had hypothesized. There was no difference 
in myotube diameter between any condition at 24 or 48 hours post-SR (Figure A.6 A and 
B). Similarly, under the control condition (high serum) MT1 and MT2 knockdown had 
no effect on myotube size or morphology (data not shown). 
 
 
                
 
 
Figure A.6: MT1 and MT2 siRNA treatment does not affect myotube atrophy. A) 
Representative images of non-treated (SR), siRNA and control siRNA treated myotubes 
at 48 hours post-SR. Scale bar equals 100µm. B) Myotube diameter of non-treated (SR), 
siRNA and control siRNA treated myotubes at 24 and 48 hours post-SR. For myotube 
diameter, data are expressed in micrometers. Shown are means ± SE from 3 independent 
experiments. 
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Discussion 
 
As early as 1992, Kondo et al. (14) first observed changes in MT expression following an 
atrophy stimulus. Since then numerous reports in both animals and humans have shown 
increased MT gene expression in response to a muscle atrophy stimulus (30-32, 38, 45). 
Inquiries into the role that MTs play during atrophy, however, are recent.  The prevailing 
hypothesis to explain rises in MT expression during atrophy has suggested that MTs may 
play a role in the oxidative stress response that accompanies muscle atrophy (49), thereby 
providing a source of protection from oxidative damage. This hypothesis is indeed 
plausible considering the reported antioxidant capacity of MTs in other tissues (46). 
Thus, we sought to test this hypothesis by knocking down the expression of the muscle-
expressed MT isoforms MT1 and MT2 prior to applying a novel atrophy stimulus in 
cultured myotubes. Contrary to our hypothesis, we found that MT1 and MT2 knockdown 
did not affect myotube atrophy or oxidant activity.  
 
The development of a novel in vitro model of muscle atrophy. Our experimental approach 
first necessitated that we develop an in vitro model of muscle atrophy in C2C12 myotubes. 
Several models of muscle atrophy have been developed previously (50, 51), most of 
which have relied on either the treatment of cell cultures with exogenous glucocorticoids 
or cytokines. However, previous work has noted the unpredictability of the effect of these 
agents on muscle culture response. For example, tumor necrosis factor-alpha (TNF-α) 
has been shown in vitro to reduce muscle protein content and promote muscle wasting 
(36). In contrast, a similar concentration of TNF-α has been demonstrated to have 
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mitogenic effects by promoting myoblast proliferation and inhibiting differentiation (50, 
52). Likewise, in our hands, both glucocorticoid and TNF-α treatment has resulted in 
varying effects on myotube size (unpublished observations). Therefore, it became 
important for us to develop and characterize a more reliable model of muscle atrophy in 
cultured myotubes.  
 
Here we have shown that a SR protocol is a simple and reliable stimulus to achieve 
atrophy of myotubes and loss of contractile protein content.  Furthermore, we have 
demonstrated this effect by the simple manipulation of standard cell culture medium, 
rather than the treatment of cultures with exogenous agents. In this, we believe that we 
have developed a model of considerable value for the future study of muscle atrophy. 
Though others have experimented with serum stimulation as a means to produce myotube 
hypertrophy (53), we are the first to use the serum-stimulated (hypertrophied) myotubes 
as a platform to then induce a muscle atrophy response via subsequent serum reduction. 
Given that fetal bovine serum (serum used in the high serum growth medium condition) 
is known to be relatively growth factor rich and horse serum (serum used in SR 
condition) to be less so, we can speculate that the difference in growth factor 
concentrations of the two sera were responsible for driving the gains and losses of 
myotube size and protein. In support of this assertion, Yoshinouchi and Baserga (54) 
showed that fibroblasts cultured in medium containing a combination of IGF-1, PDGF 
and EGF in the absence of serum had a responded similarly to fibroblasts cultured in 
medium containing 10% serum. However, further experiments would be necessary to 
tease out the individual components of the serum responsible for the observed effect. 
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We then extended these analyses to examine changes in key signaling pathways that are 
associated with muscle atrophy in vivo.  It has been shown that changes in AKT 
phosphorylation can regulate the induction of atrophy by control of the FOXO family of 
transcription factors, which control the expression of the ubiquitin E3 ligases atrogin1 
and MuRF1 (13, 55). Thus, we measured both AKT phosphorylation and expression of 
the genes atrogin1 and MuRF1 in response to SR. We observed decreases in AKT 
phosphorylation, which correlated with concomitant increases in atrogin1 and MuRF1 
mRNA abundance at 48 hours post-SR. However, it should be noted that myotube 
atrophy occurred primarily between 0 and 24 hours post-SR during which there were no 
measurable changes in AKT phosphorylation or atrogin1 and MuRF1 expression. This 
could mean that these molecular changes were not associated with myotube atrophy or 
that our detection methods were insufficiently sensitive to detect the initial changes in 
mRNA and protein abundance. While the bulk of the literature support a role for 
decreases in AKT phosphorylation following unloading or immobilization in rodents (4, 
56, 57), others have reported muscle atrophy following unloading with no associated 
changes in AKT phosphorylation or its downstream targets (58). Furthermore, unloading 
or disuse-related atrophy can be driven by changes in signaling pathways distinct to the 
AKT signaling pathway (25, 59, 60).  
 
The standard model for C2C12 cell differentiation (culture in GM followed by days of 
differentiation in DM) produces myotubes that are thinner than those generated in our 
paradigm (GM followed by DM followed by GM).  This suggests that muscle fibers used 
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in other studies may not be as robust as those generated here.  One implication of that 
possibility is that most studies with C2C12 cells may rely on myotubes that are partially 
starved, and thus do not reflect optimized cultures. 
 
Muscle atrophy and oxidative stress following MT knockdown. We chose to test our 
hypothesis using siRNA directed at the two muscle-expressed MT isoforms. Immunoblot 
analysis confirmed that we were able to significantly reduce the amount of MT protein in 
our transfected cells. Because our antibody recognized multiple isoforms of MT, we also 
show via qRT-PCR specific reductions in our targets MT1 and MT2. Contrary to our 
hypothesis, targeted knockdown of the MT isoforms MT1 and MT2 did not affect 
myotube atrophy or alter the levels of intracellular cytosolic oxidant activity in our 
model. Our observations are consistent with recent data published by DeRuisseau et al. 
(61) who also failed to detect either a decline fiber cross-sectional area or endogenous 
antioxidant enzyme expression in soleus muscles following spinal cord transection in 
MT1-/-/ MT2-/-  mice. Interestingly, they did report greater soleus muscle contractile 
impairment following spinal cord transection in these null mice. These observations, 
together with our data, suggest that MTs do not directly influence the muscle atrophy 
response. DeRuisseau et al. (61) speculate that MTs are involved in the regulation of 
calcium handling during pathologic conditions and thus may result in diminished 
contractile force. These changes in calcium homeostasis may result from the metal 
binding capacity of MT proteins. For example, regulation of zinc and other metals is 
important in modulating muscle force and work capacity in skeletal muscle (62) and 
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likely is important in zinc finger transcription factor activity and thus overall gene 
expression under various stress stimuli 
 
There are a number of published reports supporting of a role for MTs as protective 
antioxidants in various tissues (46, 63, 64). For example, Sun et al. (65) were able to 
demonstrate reduced cardiac myopathy in response to an oxidative stress stimulus using a 
MT-over-expressing transgenic mouse model. There is, however, little evidence 
supporting this role in skeletal muscle. Penkowa et al. (66) have documented increased 
expression of MT1 and MT2 protein in response to acute exercise, a stimulus known to 
increase oxidative stress. They suggested that the upregulation of MTs represented a 
response to counter oxidative stress-induced damage to muscle fibers, but there were no 
data provided to substantiate this suggestion. More recently, there was no difference 
shown in the expression of endogenous antioxidant enzymes in skeletal muscle of MT1 
and MT2 deficient mice 7 days following spinal cord transection (61). Here we show, 
with the use of an in vivo intracellular probe, that SR results in an increase in oxidant 
activity (non-specific measure of oxidative stress), but that knockdown of MT1 an MT2 
does not significantly alter that activity. Therefore, within the parameters of the 
experimental design, we could not support the hypothesis that MTs play a significant role 
in the endogenous antioxidant response to a muscle atrophy stimulus. Though clearly 
more work needs to be done to define a protective antioxidant role for MTs in skeletal 
muscle, the accumulating evidence would suggest that, if at all, they perform a minor 
function in this capacity. 
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In conclusion, we have described a novel, non-pathological in vitro model for both 
muscle atrophy and hypertrophy that may utilize more physiologically healthy muscle. 
The model requires only the manipulation of standard culture medium and thus may be of 
considerable value for future mechanistic studies of muscle atrophy. Using siRNA knock-
down methodology, we were unable to demonstrate a role of MTs 1 and 2 in either 
atrophy or intracellular oxidant activity within the limitations of our experimental design. 
These findings are corroborated by recent knockout mouse data. Together, they lend 
strong support to the notion that, despite the reports of widespread mRNA increases 
during atrophy, MTs may not play a direct functional role in the atrophy response. 
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